year
sinc
public
first
edit
mous
biomed
research
sinc
time
new
emphasi
place
mous
model
pathophysiolog
treatment
human
diseas
time
frontier
clinic
chemistri
mous
advanc
expand
two
major
event
increas
relianc
mice
biomed
research
increas
avail
practic
yet
sophist
techniqu
instrument
allow
detect
wider
varieti
biomark
diseas
progress
two
event
partial
driven
increas
regulatori
demand
relat
safetytox
assess
novel
drug
develop
abbrevi
use
chapter
summar
appendix
last
quarter
centuri
mice
frequent
use
mammal
biomed
research
rise
mammal
use
nation
center
research
resourc
natur
use
chang
dramat
time
first
half
centuri
great
deal
emphasi
place
develop
inbr
strain
avail
inbr
strain
led
major
breakthrough
cancer
biolog
immunolog
quimbi
approxim
inbr
strain
avail
addit
outbr
stock
continu
util
wide
varieti
studi
particularli
field
toxicolog
pharmacolog
second
half
centuri
investig
develop
congen
line
recombin
inbr
strain
impact
elucid
role
individu
gene
assign
new
trait
linkag
group
respect
paigen
howev
begin
earli
scientist
began
genet
engin
mice
either
ad
new
gene
transgen
delet
normal
mous
gene
knockout
ko
paigen
power
model
elucid
genet
basi
diseas
overemphas
past
year
public
cite
transgen
ko
mice
increas
exponenti
time
write
mutant
mous
resourc
jackson
laboratori
list
uniqu
line
period
result
human
mous
genom
project
publish
intern
human
genom
sequenc
consortium
mous
genom
sequenc
consortium
provid
complet
nucleotid
sequenc
genom
allow
investig
quickli
develop
equival
murin
model
mani
inherit
human
diseas
transgen
ko
mice
help
clarifi
diseas
pathogenesi
virtual
everi
area
medicin
often
elucid
biochem
pathway
previous
unknown
subject
test
quantif
result
clinic
chemistri
mous
grown
evalu
analyt
found
plasma
urin
hundr
biomark
monitor
diseas
statu
cellular
level
due
massiv
amount
new
inform
character
standard
strain
mutant
line
mice
mous
phenom
databas
develop
manag
data
provid
research
abil
explor
raw
phenotyp
data
includ
clinic
chemistri
summari
analys
resourc
allow
investig
select
appropri
murin
model
physiolog
test
drug
discoveri
toxicolog
studi
mutagenesi
model
human
diseas
quantit
trait
loci
qtl
analys
identif
new
gene
unravel
influenc
environ
genotyp
bogu
grubb
far
import
new
technolog
rapidli
grow
chang
field
clinic
chemistri
disciplin
proteom
proteom
combin
disciplin
molecular
biolog
biochemistri
genet
analysi
structur
function
interact
protein
produc
gene
particular
cell
tissu
organ
field
proteom
grown
mainli
due
develop
new
instrument
base
sophist
techniqu
yet
amen
practic
implement
exampl
develop
surfaceenhanc
laser
desorptionion
seldi
platform
timeofflight
tof
mass
spectroscopi
ms
allow
petricoin
et
al
identifi
five
peptid
sera
women
ovarian
cancer
found
women
without
ovarian
cancer
even
though
structur
function
peptid
actual
known
build
find
zhang
et
al
combin
selditof
ms
protein
separ
procedur
develop
multianalyt
immunoassay
rapidli
screen
potenti
cancer
patient
process
identifi
protein
biomark
predict
diseas
known
plasma
protein
profil
similar
technolog
use
develop
plasma
protein
profil
neoplast
condit
human
prostat
cancer
petricoin
et
al
qu
et
al
bladder
cancer
adam
et
al
vlahou
et
al
well
varieti
nonneoplast
condit
ischem
versu
hemorrhag
stroke
sever
acut
respiratori
syndrom
kang
et
al
alzheim
diseas
carrett
et
al
creutzfeldtjakob
diseas
sanchez
et
al
plasma
protein
profil
also
begun
mous
model
xiang
et
al
use
combin
twodimension
gel
electrophoresi
matrixassist
laser
desorptionion
maldi
tof
ms
quantifi
serum
protein
profil
mice
harbor
lewi
carcinoma
without
treatment
use
acetazolamid
found
upregul
mani
peptid
associ
tumor
growth
metastasi
mani
peptid
modifi
treatment
two
specif
target
acetazolamid
antitumor
activ
subsequ
identifi
histon
croci
ubclik
peptid
park
et
al
use
similar
technolog
determin
plasma
protein
profil
high
low
atherosclerosi
prone
strain
mice
normal
atherogen
diet
identifi
protein
level
chang
eat
atherogen
diet
differenti
chang
mice
addit
chang
strain
addit
protein
differenti
express
two
strain
regardless
diet
four
protein
upregul
upregul
nine
protein
marker
definit
identifi
role
pathogenesi
atherosclerosi
discuss
atherosclerosi
section
plasma
protein
profil
mice
potenti
becom
import
discoveri
tool
translat
research
particularli
identifi
cancerassoci
plasma
biomark
human
exampl
juan
et
al
also
use
maldi
tof
ms
identifi
plasma
biomark
balbcnud
mice
harbor
human
xenotranspl
tumor
mice
bear
human
stomach
cancer
cell
line
serum
amyloid
saa
elev
author
went
back
screen
sera
human
stomach
cancer
patient
abl
demonstr
compar
control
human
stomach
cancer
also
significantli
elev
level
saa
exampl
illustr
power
proteom
proteom
pattern
diagnost
offer
mean
look
molecular
diagnost
inform
human
mous
serum
without
preconceiv
assumpt
exist
ident
biomark
allow
develop
sensit
specif
peptid
assay
identifi
biomark
diseas
practic
applic
proteom
facilit
creation
instrument
analyz
multipl
analyt
small
sampl
volum
fast
throughput
multiplex
technolog
discuss
multiplex
technolog
section
attempt
manag
experiment
data
aris
field
proteom
metabolom
transcriptom
gene
array
chemic
effect
biolog
system
ceb
knowledg
base
develop
xirasagar
et
al
use
searchabl
databas
integr
experiment
find
three
disciplin
biosourc
identif
anim
test
articl
genotyp
investig
make
cross
correl
data
aris
three
differ
stream
hope
combin
group
predict
marker
diseas
toxic
emerg
cost
bring
new
drug
market
estim
billion
food
drug
administr
larg
proport
spent
safetytox
assess
preclin
phase
develop
drug
although
expens
safetytox
regul
necessari
illustr
fact
new
drug
enter
phase
clinic
trial
chanc
reach
marketplac
due
toxic
issu
abil
decreas
cost
drug
develop
due
safetytox
issu
becom
increasingli
reliant
use
laboratori
mous
model
human
diseas
identif
sensit
biomark
toxic
diseas
underli
basi
use
laboratori
mice
model
human
diseas
demonstr
everett
harrison
show
predict
reliabl
mice
quantit
toxic
five
chemotherapeut
drug
human
least
good
better
predict
reliabl
demonstr
dog
monkey
recent
newel
et
al
present
data
predict
perform
rat
mice
demonstr
qualit
human
toxic
given
novel
cancer
chemotherapeut
agent
claim
nonrod
speci
unnecessari
identif
safe
phase
start
dose
human
trial
furthermor
two
rodent
speci
rat
mice
use
gave
similar
quantit
qualit
result
arriv
genet
engin
mice
enhanc
relev
use
mice
research
especi
term
basic
mechanist
research
appli
screen
genotox
carcinogen
transgen
mice
carri
human
gene
express
protein
said
human
anim
invalu
drug
assess
especi
drug
interact
human
protein
bolon
zambrowicz
sand
show
ko
phenotyp
mice
correl
well
molecular
target
best
sell
drug
avail
us
market
zambrowicz
et
al
compar
physiolog
ko
mice
delet
gene
known
produc
novel
target
new
drug
development
pipelin
largest
pharmaceut
compani
found
target
demonstr
sound
biolog
rational
select
diseas
transgen
ko
mice
use
success
screen
new
drug
candid
safeti
elucid
basic
mechan
toxic
larg
number
drug
metabol
enzym
dme
ko
line
employ
safeti
screen
dme
may
involv
safe
metabol
drug
may
gener
toxic
intermedi
remov
dme
gene
may
result
anim
sensit
test
articl
may
provid
protect
toxic
effect
drug
instanc
ko
mice
lack
gene
increas
menadion
toxic
mice
lack
gene
resist
acetaminophen
hepatotox
henderson
wolf
murin
model
also
avail
evalu
chemic
mutagen
big
blue
mous
stratagen
la
jolla
ca
muta
mous
covanc
research
product
denver
pa
marker
gene
present
mice
differ
genet
background
bolon
ko
line
creat
increas
sensit
chemic
induc
carcinogenesi
mice
carri
singl
allel
express
hara
complet
delet
xpa
xeroderma
pigmentosum
gene
use
screen
xenobiot
vivo
bolon
transgen
ko
model
use
screen
environment
chemic
toxic
jacobsonkram
et
al
clear
mous
continu
essenti
discoveri
evalu
safeti
new
drug
equal
relev
develop
clinic
chemistri
assay
need
studi
associ
metabol
event
mice
especi
transgen
ko
line
assess
serumplasma
biomark
biomark
either
quantit
measur
biolog
effect
provid
inform
link
mechan
action
clinic
effect
surrog
marker
quantit
measur
predict
effect
arena
field
proteom
like
make
dramat
impact
clinic
chemistri
although
hope
reader
chapter
benefit
section
assay
instrument
primari
purpos
chapter
briefli
introduc
reader
area
method
clinic
chemistri
chang
provid
sourc
inform
servic
reagent
includ
test
kit
instrument
specif
test
biomark
includ
tradit
analyt
mous
serum
plasma
urin
seek
detail
descript
clinic
chemistri
method
instrument
refer
fundament
clinic
chemistri
burti
ashwood
dramat
chang
occur
past
two
decad
revolution
disciplin
clinic
chemistri
histor
analyt
measur
colorimetr
end
point
assay
base
bind
analyt
anoth
molecul
creat
new
substanc
absorb
light
specif
wavelength
analyt
newer
biomark
measur
enzymat
test
higher
specif
sensit
anoth
chang
substitut
electrochem
assay
ionselect
electrod
flame
photometri
use
quantit
sodium
potassium
perhap
chang
largest
impact
clinic
chemistri
develop
monoclon
antibodi
use
reagent
immunoassay
discuss
later
mani
commerci
compani
offer
servic
measur
analyt
biomark
blood
mice
use
combin
colorimetr
enzymat
electrochem
immunologicbas
method
mani
instrument
use
capabl
run
multipl
assay
type
simultan
use
laboratori
offer
valid
assay
specif
mous
blood
import
ensur
accur
precis
result
summari
laboratori
provid
valid
murin
assay
present
tabl
increas
avail
mousespecif
reagent
result
mani
new
assay
techniqu
provid
high
degre
sensit
specif
growth
number
reagent
capabl
quantit
analyt
mous
serum
illustr
tabl
techniqu
employ
nonisotop
label
detect
enzym
cascad
fluoresc
chemiluminesc
electrochemiluminesc
rapidli
replac
older
radioimmunoassay
ria
techniqu
enzym
immunoassay
enzymelink
immunosorb
assay
elisa
enzymemultipli
immunoassay
techniqu
emit
clone
enzym
donor
immunoassay
cedia
provid
quantit
result
base
photometr
method
enzym
immunoassay
popular
gener
compound
quantit
photometr
typic
enzymat
label
includ
galactosidas
horseradish
peroxidas
alkalin
phosphatas
addit
elisa
test
kit
compact
easi
use
quantit
inexpens
instrument
kit
usual
well
format
avail
quantit
wide
rang
mous
serum
plasma
biomark
tabl
fluoroimmunoassay
fia
util
fluoresc
molecul
indic
label
previous
subject
problem
associ
background
fluoresc
today
problem
larg
resolv
use
chelat
lanthanid
label
modif
fia
elimin
need
separ
free
bound
label
homogen
assay
chemiluminesc
electrochemilumisc
immunoassay
similar
enzym
immunoassay
except
quantit
result
base
emiss
light
chemic
label
expos
oxid
reaction
chemiluminesc
electrochem
reaction
electrochemiluminesc
number
biomark
quantifi
commerci
avail
test
kit
base
immunoassay
like
grow
unparallel
rate
result
proteom
research
mice
favor
model
mulitplex
immunoassay
uniqu
technolog
combin
four
distinct
compon
manner
allow
simultan
analysi
differ
analyt
ktl
serumplasma
core
compon
inexpens
consum
tm
diamet
polystyren
microspher
encod
differ
fluoresc
color
set
use
two
fluorophor
red
infrar
multipl
concentr
second
compon
biolog
assay
combin
matrix
metalloproteinas
tissu
inhibitor
metalloproteas
orang
fluoresc
report
molecul
built
onto
surfac
microspher
divers
rang
biolog
assay
built
onto
microspher
surfac
includ
immunoassay
nucleic
acid
assay
enzymat
reaction
assay
receptorligand
analysi
assay
third
compon
flow
cytomet
focus
microspher
singl
file
front
two
interrog
laser
allow
high
throughout
one
laser
red
diod
emit
nm
illumin
microspher
result
red
infrar
fluoresc
provid
classif
inform
particular
microspher
set
laser
green
yag
diod
emit
nm
excit
orang
fluoresc
report
molecul
surfac
microspher
provid
quantit
signal
particular
biolog
assay
last
compon
digit
signal
process
data
acquisit
hardwar
provid
speed
necessari
read
microspher
per
second
multiplex
technolog
analyz
wide
rang
biomark
simultan
dynam
refer
result
plasma
profil
develop
base
chang
concentr
biomark
cours
diseas
known
potenti
applic
develop
plasma
profil
diseas
power
plasma
profil
use
screen
identifi
diseas
especi
earli
develop
diseas
character
efficaci
drug
target
diseas
multiplex
technolog
help
elucid
new
biomark
diseas
furthermor
plasma
profil
could
also
potenti
develop
monitor
blood
concentr
drug
well
investig
seek
addit
inform
avail
reagent
test
kit
refer
clinic
laboratori
refer
nelson
linscott
directori
immunolog
biolog
reagent
linscott
section
two
refer
provid
name
address
sourc
catalog
individu
compani
may
fruit
mani
reagent
use
human
blood
valid
use
speci
includ
mous
variou
instrument
mention
section
may
found
annual
analyz
buyer
guid
advanc
administr
laboratori
guid
list
manufactur
give
detail
inform
instrument
includ
technolog
platform
method
use
throughput
capabl
purchas
price
mainten
cost
reagent
packag
cost
well
varieti
option
avail
contact
inform
includ
web
site
avail
manufactur
addit
inform
regard
clinic
chemistri
anim
blood
avail
web
site
divis
anim
clinic
chemistri
american
associ
clinic
chemistri
wwwaaccorgdivisionsanim
mean
bodi
size
g
adult
mice
approxim
ml
blood
volum
allow
tl
remov
weekli
without
consequ
health
welfar
loeb
loeb
quimbi
four
blood
collect
site
acquir
tl
blood
repetit
adult
mice
includ
orbit
plexu
tail
vein
jugular
vein
cardiac
punctur
quimbi
gener
anesthesia
recommend
orbit
plexu
cardiac
punctur
although
terril
robb
et
al
claim
topic
applic
proparacain
hydrochlorid
accept
procedur
collect
orbit
plexu
blood
jugular
vein
punctur
use
lancet
direct
rear
jaw
expos
jugular
vein
tributari
submandibular
facial
vein
gold
et
al
collect
blood
vein
site
work
well
anim
requir
anesthesia
restraint
devic
blood
collect
small
centrifug
tube
capillari
tube
nerenberg
zedler
describ
vacuum
apparatu
use
collect
larger
volum
blood
tail
vein
lewi
et
al
found
heparin
mice
tail
bleed
increas
yield
prewarm
mous
lamp
immers
warm
water
facilit
tail
bleed
use
heparin
microhematocrit
tube
tail
orbit
plexu
bleed
maxim
plasma
volum
minim
hemolysi
quimbi
hem
smith
recommend
saphen
vein
prick
method
orbit
plexu
method
collect
repeat
small
volum
consciou
mice
macleod
shapiro
use
indwel
fight
atrial
cathet
repetit
bleed
consciou
unstress
mice
disadvantag
specif
procedur
describ
sakaki
et
al
report
sympathet
nervou
system
stimul
associ
tail
bleed
mix
venou
arteri
blood
orbit
plexu
method
patrick
et
al
found
compar
jugular
vein
collect
cardiac
punctur
associ
higher
plasma
glucos
concentr
lower
creatin
kinas
ck
activ
plasma
glucos
concentr
higher
blood
collect
orbit
sinu
compar
tail
vein
differ
associ
method
anesthesia
also
import
halothan
methoxyfluran
isofluran
pentobarbit
sodium
wide
use
consid
safe
howev
caution
exercis
interpret
certain
chemistri
valu
higher
plasma
glucos
level
report
tail
vein
sampl
mice
anesthet
pentobarbit
methoxyfluran
compar
consciou
mice
chuang
luo
plasma
glucos
level
higher
collect
orbit
plexu
pentobarbit
proparacain
hydrochlorid
administ
methoxyfluran
glucos
elev
effect
sampl
collect
orbit
plexu
cunliffebeam
claim
carbon
dioxid
narcosi
provid
sedat
analges
minut
appropri
anesthet
orbit
plexu
bleed
greater
volum
blood
requir
four
collect
site
use
requir
anesthesia
subsequ
euthanasia
mous
site
includ
jugular
vein
ambru
et
al
abdomin
aorta
lushbough
molin
brachial
arteri
young
chamber
heart
cubitt
barrett
mitruka
rawnsley
blood
collect
newborn
mous
accomplish
decapit
inject
two
unit
heparin
subcutan
sever
minut
decapit
may
allow
collect
tl
blood
tl
plasma
although
collect
urin
possibl
mice
impract
due
anatom
physiolog
restrict
total
urinari
bladder
volum
less
ml
total
urinari
output
per
day
less
ml
jung
et
al
mean
mice
frequent
mictur
restrict
amount
urin
collect
one
time
point
therefor
also
restrict
number
analyt
assess
one
urin
sampl
abl
collect
enough
urin
assess
singl
live
mous
mice
place
plastic
cage
without
absorb
bed
materi
urin
collect
bottom
cage
h
howev
disadvantag
techniqu
urin
expos
contamin
fece
environment
contamin
organ
pool
urin
sampl
collect
group
live
mice
use
techniqu
increas
total
amount
urin
collect
allow
specif
result
relat
back
specif
individu
group
mice
remov
quickli
cage
held
piec
parafilm
frequent
void
parafilm
help
prevent
urin
spread
urin
also
collect
directli
urinari
bladder
mice
euthanasia
techniqu
allow
steril
sampl
volum
collect
restrict
total
urinari
bladder
volum
ml
often
volum
much
less
mice
typic
void
urin
urinari
bladder
time
death
refer
rang
refer
rang
analyt
biomark
popul
select
presenc
diseas
abnorm
refer
rang
usual
gener
larg
number
individu
popul
refer
rang
analyt
biomark
vari
two
differ
popul
tabl
list
refer
rang
select
analyt
two
inbr
strain
outbr
stock
situat
refer
rang
publish
gener
laboratori
reli
accur
variabl
known
advers
affect
host
includ
environment
factor
pathogen
shipment
addit
nutrit
time
sampl
collect
storag
techniqu
may
contribut
variabl
age
effect
analyt
mous
earli
studi
barrett
et
al
found
serum
calcium
level
afg
inbr
mice
signific
higher
mice
strain
recent
comprehens
analys
complet
loeb
et
al
reinforc
effect
age
clinic
chemistri
paramet
five
inbr
strain
two
hybrid
includ
serum
protein
effect
sex
chemistri
paramet
demonstr
sex
hormon
includ
folliclestimul
hormon
fsh
lutein
hormon
lh
progesteron
tabl
illustr
differ
male
femal
mice
femal
mice
estru
estru
strainassoci
chang
appear
healthi
anim
document
complement
compon
goldman
goldman
cholesterol
dunnington
et
al
mead
gore
testosteron
ivanyi
et
al
cortisolbind
protein
goldman
et
al
serum
protein
borovkov
svirdov
loeb
cyclic
biorhythm
whether
circadian
ultradian
influenc
blood
level
variou
analyt
mice
blood
level
adrenocorticotrop
hormon
acth
corticosteron
growth
hormon
gh
lh
may
peak
one
time
daili
thu
special
attent
must
given
time
collect
order
sampl
individu
group
betweengroup
comparison
made
loeb
degre
hydrat
exposur
nois
degre
confin
environment
temperatur
shown
affect
serum
chemistri
analyt
quimbi
diet
known
influenc
blood
level
mani
analyt
perhap
best
studi
effect
atherogen
diet
serum
cholesterol
similarli
signific
differ
serum
cholesterol
urea
nitrogen
seen
mice
maindetermin
presenc
absenc
diseas
abnorm
tain
semipurifi
diet
mous
uniqu
situat
includ
evalu
analyt
biomark
j
among
mammal
murin
muscl
contain
transgen
ko
mous
popul
especi
experi
popul
size
small
evalu
certain
analyt
biomark
assess
immun
function
instead
baselin
data
compil
control
popul
wildtyp
mice
transgen
ko
mice
deriv
use
use
compil
baselin
data
depend
control
larg
number
variabl
known
influenc
chemistri
determin
sever
studi
demonstr
signific
differ
select
serum
analyt
concentr
age
differ
strain
sex
strain
among
strain
everett
harrison
carnosin
anserin
carnosin
serv
sourc
histidin
histidin
restrict
unlik
mammal
mice
histidinefre
diet
show
sign
histidin
defici
fast
may
also
affect
level
certain
analyt
quimbi
presenc
absenc
axen
mice
intestin
microbi
flora
associ
dramat
chang
immunoglobulin
ig
level
may
associ
chang
analyt
well
exampl
axen
mice
significantli
lower
level
iga
compar
convent
mice
moreau
et
al
presenc
pathogen
may
associ
dramat
chang
variou
analyt
even
subclin
infect
instanc
infect
lactic
dehydrogenaseelev
viru
ldv
associ
major
elev
serum
lactic
dehydrogenas
isocitr
dehydrogenas
malic
dehydrogenas
aspart
aminotransferas
glutathion
reductas
activ
quimbi
asummar
loeb
quimbi
alter
clinicopatholog
paramet
attribut
stress
mice
landi
et
al
found
plasma
corticosteron
concentr
mice
test
within
h
arriv
plane
truck
transport
significantli
higher
test
h
post
arriv
mice
sensit
arriv
sheep
red
cell
antigen
significantli
lower
antibodi
titer
fewer
plaqueform
cell
decreas
delay
type
hypersensit
reaction
compar
normal
mice
allow
acclim
facil
h
sensit
elev
serum
corticosteron
level
aris
excess
handl
mice
prior
blood
collect
effect
sampl
storag
variou
temperatur
vari
period
describ
falk
et
al
evalu
effect
storag
time
freez
serum
analyt
six
laboratori
speci
found
mous
creatin
kinas
activ
chang
significantli
storag
day
hemolysi
common
problem
blood
collect
mice
hemolyz
sampl
associ
chang
variou
enzym
increas
ck
activ
decreas
lipas
activ
minim
everett
harrison
recommend
heparin
plasma
care
select
collect
site
routin
chemic
determin
effect
lipemia
variou
anticoagul
pharmacolog
agent
clinic
chemistri
valu
review
domest
anim
meyer
harvey
use
sever
method
regardless
distribut
data
gener
use
describ
limit
includ
test
result
diseasefre
popul
valu
exhibit
gaussian
distribut
parametr
method
mean
standard
deviat
appropri
gaussian
distribut
data
rang
includ
two
standard
deviat
mean
certain
murin
analyt
nongaussian
distribut
must
evalu
use
nonparametr
method
varieti
method
avail
includ
percentil
method
logarithmtransform
data
analyz
parametr
method
method
percentil
estim
vulner
bia
due
extrem
valu
outlier
logtransform
parametr
method
boyd
assert
sampl
size
least
requir
give
confid
interv
use
percentil
method
wherea
sampl
size
may
give
reliabl
rang
parametr
analys
use
neither
statist
method
describ
replac
raw
data
certain
situat
assess
analyt
immun
function
use
data
deriv
wildtyp
mice
comparison
baselin
data
transgen
ko
mice
issu
qualiti
control
test
valid
thoroughli
discuss
common
domest
anim
applic
chemistri
determin
mice
meyer
harvey
qualiti
assur
clinic
chemistri
determin
import
ensur
consist
accur
precis
result
achiev
everett
harrison
stress
import
clinic
patholog
qualiti
assur
program
includ
regular
assay
pool
commerci
prepar
preassay
sera
addit
encourag
particip
subscript
qualiti
assur
program
veterinari
laboratori
associ
withinday
daytoday
coeffici
variat
known
analyt
measur
due
tremend
number
variabl
known
influenc
clinic
chemistri
valu
mice
often
prudent
test
adequ
number
control
specimen
along
experiment
sampl
techniqu
often
impract
test
conduct
strictli
diagnost
purpos
situat
compil
valu
control
mani
variabl
possibl
may
suffici
valu
defin
refer
rang
particular
analyt
biomark
normal
healthi
mice
may
describ
section
intend
serv
review
specif
test
routin
analyt
addit
comprehens
discuss
present
analyt
biomark
involv
two
area
translat
research
intens
interest
obesitydiabet
atherosclerosi
novel
biomark
diseas
immun
function
test
analyt
biomark
current
avail
commerci
test
mice
serum
plasma
andor
urin
discuss
certain
analyt
biomark
commerci
avail
test
avail
mous
calcitonin
cover
complet
inform
routin
analyt
pleas
refer
loeb
quimbi
glucos
main
sourc
energi
mice
blood
glucos
concentr
depend
rate
entri
remov
rate
blood
rate
entri
depend
intestin
absorpt
dietari
sourc
glucos
breakdown
bodi
glycogen
store
glycogenolysi
synthesi
gluconeogen
metabolit
gluconeogenesi
remov
rate
mainli
depend
insulin
releas
pancreat
islet
insulin
promot
cellular
uptak
blood
glucos
mainli
muscl
liver
fat
stimul
transloc
glucos
transport
cell
membran
remov
circul
blood
glucos
may
either
util
maintain
cell
function
convert
fat
glycogen
liver
muscl
energi
store
howev
effect
insulin
modul
hormon
glucagon
corticosteron
gh
epinephrin
somatostatin
amylin
ultim
result
tight
control
level
blood
glucos
depend
tissu
demand
energi
glucagon
releas
tcell
pancreat
islet
respons
low
circul
glucos
stimul
liver
increas
circul
glucos
glycogenolysi
gluconeogenesi
corticosteron
gh
antagon
action
insulin
epinephrin
suppress
insulin
releas
stimul
glucagon
releas
glycogenolysi
somatostatin
suppress
insulin
glucagon
secret
wherea
amylin
increas
blood
glucos
blood
insulin
insulin
resist
burti
ashwood
kaneko
glucos
determin
gener
conduct
fresh
serum
howev
plasma
glucos
determin
accept
delay
greater
minut
separ
erythrocyt
anticip
case
fluorid
use
anticoagul
inhibit
glycolysi
erythrocyt
blood
glucos
mice
measur
use
hexokinas
glucos
oxidas
test
may
perform
analyt
method
use
glucos
oxidas
coat
test
strip
urin
glucos
small
portabl
analyz
seidelmann
et
al
assess
longterm
averag
blood
glucos
level
mice
also
avail
ria
measur
glycosyl
hemoglobin
glycosyl
serum
protein
collect
known
fructosamin
gould
et
al
mous
phenom
databas
list
serum
glucos
level
strain
blood
collect
fast
week
old
male
femal
standard
laboratori
diet
mice
overal
mean
mgdl
naggert
et
al
blood
glucos
level
vari
age
sex
strain
femal
strain
tend
lower
level
male
lpj
mice
show
lowest
valu
f
mgdl
mice
show
highest
valu
f
mgdl
mice
serum
glucos
level
decreas
month
age
balbc
strain
glucos
level
rise
month
loeb
serum
plasma
glucos
level
may
also
vari
depend
site
collect
anesthet
use
quimbi
patrick
et
al
found
compar
jugular
vein
collect
cardiac
punctur
associ
higher
blood
glucos
differ
associ
method
anesthesia
also
import
higher
plasma
glucos
level
report
tail
vein
sampl
either
pentobarbit
methoxyfluran
compar
sampl
consciou
mice
chuang
luo
plasma
glucos
level
higher
orbit
plexu
sampl
mice
pentobarbit
proparacain
hydrochlorid
provid
methoxyfluran
glucos
elev
effect
sampl
collect
orbit
plexu
howev
consciou
anim
plasma
glucos
level
higher
blood
collect
retroorbit
sinu
compar
tail
bleed
hyperglycemia
increas
blood
glucos
level
mous
due
increas
peripher
resist
tissu
insulin
exogen
corticosteroid
administr
increas
endogen
corticosteron
releas
glucagon
administr
gh
administr
diabet
see
discuss
later
hypoglycemia
decreas
blood
glucos
level
due
excess
circul
insulin
excess
insulin
administr
transgen
mice
tumor
pancreat
islet
reduc
glycogen
store
advanc
liver
diseas
excess
glucos
use
pregnanc
septicemia
neoplasia
reduc
glucos
intak
starvat
diseas
malabsorpt
diabet
mice
defin
persist
blood
glucos
level
greater
mgdl
fast
mice
level
also
correspond
renal
threshold
glucos
urin
excret
mice
urin
glucos
assess
use
regard
mice
nonobes
diabet
mice
model
type
diabet
nonfast
plasma
glucos
level
young
prediabet
mice
mgdl
rise
mgdl
week
age
leiter
genet
modifi
mice
identifi
virtual
everi
ligand
receptor
regul
glucos
metabol
depend
gene
mutat
may
exhibit
alter
level
plasma
glucos
exampl
adenosin
monophosphateactiv
protein
kinas
ampk
critic
enzym
energi
metabol
includ
cellular
glucos
uptak
fatti
acid
oxid
muscl
fatti
acid
synthesi
gluconeogenesi
hepatocyt
use
ko
mice
shaw
et
al
demonstr
kinas
lkb
import
activ
ampk
liver
energystress
condit
ko
mice
defici
kinas
persist
hyperglycem
author
also
demonstr
kinas
lkb
target
type
diabet
therapeut
drug
metformin
glucos
toler
test
gtt
perform
mice
one
test
conduct
test
glucos
concentr
evalu
h
follow
administr
mgg
glucos
administ
intraperiton
ip
oldston
et
al
test
compar
preinject
serum
serum
collect
minut
follow
administr
mgg
glucos
given
ip
hotamisligil
et
al
sensit
gtt
also
describ
mice
given
mlkg
glucos
oral
gate
et
al
hypoglycem
respons
insulin
mice
also
describ
hotamisligil
et
al
kaku
et
al
measur
glucos
glycosyl
hemoglobin
insulin
level
six
inbr
strain
undergo
gtt
either
fed
fast
mice
estim
number
gene
involv
phenotyp
differ
glucos
toler
least
glucos
toler
strain
bred
toler
strain
hybrid
backcross
anim
test
author
conclud
glucos
toler
six
commonli
use
inbr
strain
polygen
trait
thrifti
gene
hypothes
give
earli
human
huntergather
surviv
advantag
provid
econom
mechan
store
energi
period
famin
zimmet
thoma
effici
mechan
energi
storag
promot
adipos
tissu
seem
reason
least
thrifti
gene
may
function
manner
anoth
hypothesi
hold
period
famin
essenti
conserv
glucos
use
brain
mechan
respons
involv
insulin
resist
peripher
tissu
neel
hypothes
true
easi
envis
associ
obes
type
diabet
especi
sedentari
lifestyl
unrestrict
access
food
occur
togeth
lazar
one
candid
thrifti
gene
encod
hormon
leptin
leptin
produc
adipos
tissu
absenc
lead
obes
insulin
resist
time
high
adipos
storag
blood
level
leptin
high
promot
energi
metabol
inhibit
food
intak
opposit
occur
starvat
leptin
one
number
adipokin
secret
adipos
tissu
aid
regul
appetit
metabol
fact
locat
adipos
tissu
size
averag
adipocyt
adipocyt
metabol
glucos
corticosteroid
modifi
endocrin
function
adipos
tissu
lazar
among
protein
secret
adipos
tissu
adiponectin
adipsin
resistin
visfatin
tumor
necrosi
factora
tnfa
macrophag
chemoattract
plasminogen
activ
angiotensinogen
saa
aacid
glycoprotein
like
adipocytederiv
free
fatti
acid
shown
contribut
insulin
resist
liver
muscl
protein
capabl
modul
glucos
metabol
insulin
action
adiponectin
visfatin
work
synergist
insulin
enhanc
glucos
uptak
muscl
block
glucos
synthesi
liver
hug
lodish
blood
level
visfatin
increas
obes
cytokin
bind
stimul
insulin
receptor
fukuhara
et
al
blood
level
adiponectin
neg
correl
bodi
mass
lower
obes
human
mice
suggest
reduc
mrna
express
adiponectin
gene
may
involv
obes
masaki
et
al
increas
adiponectin
downregul
hepat
express
tnfa
mediat
antidiabetogen
effect
via
receptor
peripher
tissu
especi
liver
tnfa
resistin
induc
resist
insulin
howev
tnfa
also
suppress
express
adipocyt
specif
fred
w
quimbi
richard
h
luong
gene
resistin
maintain
glucos
fast
product
increas
obes
cytokin
tnf
proinflammatori
also
produc
monocyt
act
liver
produc
acut
phase
reactant
also
induc
suppressor
cytokin
intracellular
signal
molecul
impair
neuron
signal
leptin
insulin
thu
caus
resist
central
action
hormon
schwartz
port
resistin
mediat
effect
princip
decreas
express
gluconeogen
enzym
liver
banerje
et
al
certain
cytokin
increas
endoplasm
reticulum
stress
chronic
hyperglycemia
chronic
hyperlipidemia
oxid
stress
may
induc
apoptosi
insulin
produc
lcell
islet
pancrea
rhode
insulin
receptor
key
molecul
promot
cell
growth
surviv
molecul
act
immedi
downstream
surfac
receptor
insulin
insulinlik
growth
inhibit
shown
lead
insulin
resist
inhibit
may
result
accumul
reactiv
oxygen
speci
cell
chronic
expos
increas
glucos
metabol
chronic
exposur
elev
fatti
acid
product
long
chain
acylcoa
activ
protein
kinas
cisoform
degrad
leptin
shown
modul
interleukinl
ili
potent
induc
apoptosi
tnft
induc
cell
apoptosi
activ
transcript
factor
nuclear
factor
k
nf
central
action
insulin
leptin
take
place
mediobas
hypothalamu
neuron
exert
potent
effect
food
intak
energi
expenditur
neuron
coexpress
neuropeptid
npi
agoutirel
peptid
agrp
stimul
food
intak
reduc
energi
expenditur
leptin
insulin
inhibit
neuron
condit
reduc
leptin
insulin
signal
npi
increas
induc
hyperphagia
weight
gain
insulin
resist
glucos
intoler
anabol
effect
agrp
aris
antagon
melanocortin
receptor
serv
limit
food
intak
blockag
lead
weight
gain
insulin
resist
precursor
proopiomelanocortin
pomc
pomc
neuron
arcuat
nucleu
stimul
leptin
insulin
result
product
melanocortin
bind
inhibit
food
intak
promot
weight
loss
schwartz
port
howev
absenc
leptin
seen
lep
mice
neuron
arcuat
nucleu
hypothalamu
perman
disrupt
treatment
adulthood
revers
defect
bouret
et
al
orexin
orexin
b
neuropeptid
produc
later
hypothalamu
neuron
axon
project
mani
site
includ
control
feed
behavior
sleepwak
taylor
samson
orexin
ko
mice
develop
hypophagia
obes
insulinresist
diabet
hara
et
al
ghrelin
peptid
made
predominantli
stomach
also
known
act
central
affect
food
intak
increas
secret
gh
ghigo
et
al
korbonit
et
al
peripheri
leptin
shown
specif
repress
rna
level
enzymat
activ
hepat
stearoylcoa
catalyz
biosynthesi
monounsatur
fatti
acid
effect
found
import
metabol
action
leptin
cohen
et
al
leptin
resist
common
featur
obes
mice
human
also
shown
result
part
shed
membranebound
hepat
leptin
receptor
plasma
solubl
receptor
modul
circul
leptin
level
possibl
biolog
activ
cohen
et
al
thu
connect
factor
regul
obes
insulin
resist
diabet
complex
occur
central
peripher
investig
mice
involv
quantifi
glucos
adipokin
insulin
leptin
solubl
leptin
receptor
discuss
mous
model
obes
diabet
pleas
refer
chapter
text
metabol
food
intak
insulin
leptin
amylin
also
call
islet
amyloid
polypeptid
iapp
glucagon
ghrelin
obestatin
orexin
orexin
b
gh
corticosteron
measur
mice
ria
elisa
kit
commerci
avail
see
tabl
addit
hormon
may
measur
part
multiplex
panel
see
multiplex
technolog
section
leptin
valu
fvbn
strain
rang
ngml
insulin
valu
rang
iuml
corticosteron
level
rang
tgdl
gh
rang
tgml
epinephrin
measur
ria
rang
mice
pgdl
depaolo
masoro
adipokin
secret
entir
adipos
tissu
includ
adiponectin
adipsin
resistin
adiponectin
resistin
measur
mous
serum
commerci
elisa
test
kit
avail
speci
polyclon
antibodi
crossreact
conserv
sequenc
mous
adipsin
creat
searfoss
et
al
tnfct
visfatin
adipokin
synthes
also
macrophag
lymphocyt
provid
common
link
regul
obes
resist
insulin
inflamm
lazar
tnft
may
measur
commerci
avail
elisa
kit
see
cytokin
chemokin
section
method
also
publish
measur
visfatin
fukuhara
et
al
reagent
quantifi
solubl
leptin
receptor
commerci
avail
time
although
method
measur
analyt
mous
serum
publish
cohen
et
al
cohen
et
al
four
main
type
lipid
plasma
free
cholesterol
esterifi
cholesterol
triglycerid
phospholipid
lipid
deriv
diet
mainli
longchain
fatti
acid
although
endogen
recycl
mainli
liver
occur
plasma
lipid
poor
water
solubl
thu
requir
watersolubl
protein
molecul
transport
plasma
complex
plasma
lipid
protein
known
apoprotein
also
known
apolipoprotein
contain
core
nonpolar
lipid
surround
surfac
layer
phospholipid
free
cholesterol
apoprotein
apoprotein
classifi
accord
physic
chemic
paramet
includ
order
increas
densiti
chylomicron
lowdens
lipoprotein
vldl
intermedi
densiti
lipoprotein
idl
lowdens
lipoprotein
ldl
highdens
lipoprotein
hdl
particl
densiti
proport
relat
amount
phospholipid
protein
triglycerid
contain
increas
particl
densiti
correspond
increas
proport
phospholipid
protein
decreas
densiti
correspond
decreas
proport
triglycerid
chylomicron
vldl
often
refer
triglyceriderich
lipoprotein
apoprotein
surfac
particl
serv
ligand
receptor
cofactor
enzym
interact
structur
compon
wagner
et
al
tabl
list
mous
apoprotein
describ
known
function
largest
lipoprotein
particl
chylomicron
transport
dietari
lipid
form
triglycerid
intestin
chylomicron
contain
apoprotein
absorb
lymphat
intestin
eventu
enter
blood
deliv
fatti
acid
tissu
assist
lipoprotein
lipas
lpl
releas
glycerol
blood
chylomicron
lose
triglycerid
becom
smaller
call
remnant
remnant
acquir
apoprotein
e
plasma
hdl
rapidli
clear
liver
apoprotein
e
receptor
chylomicron
remnant
receptor
vldl
second
preval
lipoprotein
particl
normal
mous
blood
hdl
transport
triglycerid
liver
extrahepat
tissu
vldl
synthes
liver
apoprotein
b
c
e
attach
lpl
aid
releas
fatti
acid
triglycerid
peripher
tissu
ldl
present
low
concentr
normal
mice
carri
cholesterol
extrahepat
tissu
ldl
contain
apoprotein
b
primari
sourc
cholesterol
deposit
intima
arteri
mice
apoprotein
b
bind
ldl
receptor
ldlr
hdl
synthes
liver
contain
larg
amount
free
cholesterol
apoprotein
c
e
metabol
hdl
free
cholesterol
esterifi
action
lecithin
cholesterol
acyltransferas
lcat
exchang
cholesterol
ester
triglycerid
vldl
result
less
dens
hdl
subfract
complet
remov
circul
liver
exchang
esterifi
cholesterol
triglycerid
mediat
cholesteryl
ester
transfer
protein
cetp
human
howev
activ
absent
mice
phospholipid
transfer
vldl
hdl
mediat
phospholipid
transfer
protein
pltp
high
level
solubl
hepat
lipas
found
mous
plasma
lusi
wagner
et
al
hdl
thought
transport
cholesterol
peripher
tissu
liver
process
known
revers
cholesterol
transport
rct
process
believ
facilit
adenosin
triphosph
atp
bind
cassett
transport
transport
phospholipid
cholesterol
acceptor
apoprotein
apoprotein
e
aiello
et
al
hdl
also
serv
reserv
apoprotein
c
apoprotein
e
necessari
vldl
metabol
tabl
list
apolipoprotein
receptor
found
mice
describ
ligand
function
atherosclerosi
major
factor
heart
diseas
stroke
peripher
vascular
diseas
human
princip
caus
death
western
countri
etiolog
complex
involv
genet
environment
compon
although
exampl
singl
gene
defect
human
lead
atherosclerosi
condit
rare
explain
diseas
preval
atherosclerosi
character
format
plaqu
intima
larg
medium
size
arteri
usual
locat
blood
flow
disturb
plaqu
contain
varieti
cell
includ
endotheli
cell
monocyt
macrophag
smooth
muscl
cell
lymphocyt
secret
product
modul
progress
plaqu
format
addit
plaqu
contain
complex
mix
collagen
proteoglycan
occasion
cartilagin
tissu
calcif
lipoprotein
primarili
ldl
diseas
risk
correl
directli
elev
circul
level
ldl
cholesterol
risk
indirectli
correl
level
hdl
thu
although
ldl
promot
atherosclerosi
hdl
protect
nation
cholesterol
educ
program
combin
high
ldl
low
hdl
term
dyslipidemia
found
human
patient
insulin
resist
syndrom
mice
develop
spontan
atherosclerosi
low
circul
level
ldl
lack
cetp
activ
howev
genet
engin
mice
overor
underexpress
gene
involv
lipid
metabol
contribut
greatli
understand
lipoprotein
metabol
marschang
herz
particular
transgen
mice
develop
plasma
lipid
profil
similar
human
atherosclerosi
breslow
breslow
human
transgen
mice
elev
ldl
low
hdl
ldl
passiv
diffus
across
endothelium
especi
area
endotheli
cell
morpholog
alter
sheer
forc
gener
blood
turbul
ldl
within
intima
interact
ldlapoprotein
b
matrix
proteoglycan
result
ldl
trap
ldl
undergo
modif
associ
oxid
lipolysi
proteolysi
aggreg
contribut
inflamm
uptak
ldl
tissu
macrophag
lipoxygenas
lo
insert
molecular
oxygen
polyeno
fatti
acid
produc
hydroperoxyeicosatetraeno
acid
hete
endotheli
cell
releas
hete
vessel
wall
initi
oxid
ldl
oxid
ldl
aid
myeloperoxidas
sphingomyelinas
mice
lack
lo
diminish
atherosclerosi
macrophag
monocyt
recogn
oxid
ldl
via
surfac
scaveng
receptor
becom
load
cholesterol
ester
form
fatti
streak
appear
along
vessel
wall
hdl
hand
remov
excess
cholesterol
peripher
tissu
inhibit
lipoprotein
oxid
hdl
carri
paraoxonas
degrad
oxid
phospholipid
lusi
protect
subsequ
oxid
damag
oxid
ldl
stimul
endotheli
cell
express
adhes
molecul
icam
vcam
monocyt
colonystimul
factor
mcsf
lumin
surfac
attract
addit
monocyt
lymphocyt
oxid
ldl
also
inhibit
nitric
oxid
product
infiltr
thymicderiv
lymphocyt
cell
macrophag
initi
migrat
smooth
muscl
cell
media
intima
synthes
matrix
compon
also
releas
macrophag
induc
monocyt
differenti
migrat
scaveng
receptor
express
accumul
excess
free
cholesterol
inhibit
activ
acyl
coa
cholesterol
acyltransferas
acat
mediat
cholesterol
esterif
cellular
cholesterol
effiux
one
mechan
respons
cholesterol
effiux
secret
apoprotein
e
macrophag
promot
effiux
via
hdl
fail
case
cholesterolladen
macrophag
plaqu
apoptosi
macrophag
ensu
load
endoplasm
reticulum
free
cholesterol
activ
er
resid
protein
kinas
unfold
protein
respons
upr
initi
apoptosi
activ
feng
et
al
macrophag
undergo
apoptosi
creat
necrot
core
plaqu
promot
extracellular
cholesterol
cleft
format
smooth
muscl
cell
creat
fibrou
cap
plaqu
near
lumin
surfac
lesion
advanc
cell
activ
ligat
releas
cytokin
ifni
tnfct
substanc
activ
matrix
degrad
proteas
adhes
molecul
promot
addit
inflamm
inflamm
progress
fibrou
cap
becom
compromis
lead
physic
ruptur
gener
thrombogen
surfac
oxid
ldl
increas
product
tissu
factor
thrombogen
surfac
initi
coagul
cascad
thrombu
format
detail
elucid
use
genet
modifi
mice
auerbach
et
al
choudhuri
et
al
feng
et
al
lusi
reardon
getz
tailleux
et
al
trigatti
et
al
discuss
model
reader
urg
read
chapter
book
measur
plasma
lipid
serum
prefer
sampl
serum
store
day
without
advers
effect
measur
serum
cholesterol
triglycerid
serum
cholesterol
mice
measur
use
enzymat
oxid
method
roschlay
mead
gore
lipid
research
clinic
program
protocol
morrisett
et
al
abel
techniqu
mitruka
rawnsley
common
enzymat
method
employ
cholesterol
ester
hydrolas
convert
cholesterol
ester
cholesterol
cholesterol
oxidas
oxid
cholesterol
hydrogen
peroxid
peroxidas
catalyz
reaction
involv
hydrogen
peroxid
phenol
form
dye
quinonelmin
compon
test
combin
singl
reagent
mix
dye
absorb
measur
nm
choudhuri
et
al
triglycerid
tg
level
mainli
reflect
tg
content
chylomicron
vldl
mous
quantifi
use
varieti
enzymat
method
popular
method
combin
lipoprotein
lipas
glycerol
kinas
glycerolphosph
oxidas
peroxidas
usual
two
reagent
method
serum
tg
convert
glycerol
lpl
via
hydrolysi
next
glycerol
phosphoryl
atpdepend
reaction
catalyz
glycerol
kinas
glycerolphosph
catalyz
dihydroxyaceton
hydrogen
peroxid
glycerophosph
oxidas
peroxidas
catalyz
final
reaction
peroxid
convert
stabl
dye
absorb
read
nm
tsimika
et
al
reagent
total
cholesterol
total
tg
may
use
autom
analyz
purchas
directli
chemic
compani
instruct
manual
laboratori
analysi
total
serum
cholesterol
tg
level
vari
strain
gender
age
length
fast
diet
jiao
et
al
studi
total
plasma
cholesterol
tpc
tg
level
variou
inbr
strain
fed
standard
diet
h
fast
tpc
level
rang
mgdl
akrj
mgdl
nzbb
tg
level
rang
mgdl
mgdl
much
lower
seen
normal
human
alber
piagen
quantifi
total
cholesterol
level
strain
give
standard
laboratori
diet
fast
h
blood
collect
level
mice
vari
greatli
strain
femal
lowest
level
mgdl
nzbb
male
highest
level
mgdl
given
strain
male
alway
higher
level
femal
trend
total
hdl
level
strain
parallel
total
cholesterol
level
triglycerid
level
also
vari
greatli
among
strain
parallel
cholesterol
level
among
strain
test
mice
lowest
tg
level
mgdl
highest
f
mgdl
mgdl
differ
gender
strain
less
pronounc
compar
cholesterol
male
gener
higher
level
femal
transient
caus
plasma
lipid
elev
hyperlipidemia
mous
relat
recent
feed
postprandi
hyperlipidemia
especi
highfat
diet
caus
persist
hyperlipidemia
includ
diabet
sustain
feed
highfat
diet
nephrot
syndrom
b
hdl
ldl
idl
vldl
level
individu
apolipoprotein
measur
densiti
gradient
ultracentrifug
combin
either
electrophoret
immunolog
chemic
morpholog
analys
although
publish
refer
rang
avail
distribut
character
murin
apoprotein
report
camu
et
al
similar
method
use
evalu
plasma
apoprotein
mice
consum
atherogen
diet
moltisett
et
al
recent
profil
murin
plasma
lipoprotein
cholesterol
determin
fast
protein
liquid
chromatographi
onlin
postcolumn
analysi
superos
gelfiltr
eluat
sehayek
et
al
strauss
et
al
contrast
human
mice
normal
low
level
ldl
plasma
mgdl
major
plasma
lipoprotein
hdl
low
ldl
concentr
due
edit
apoprotein
b
mrna
transcript
mous
liver
lead
apoprotein
contain
particl
clear
much
faster
ldl
human
lusi
contrast
human
apoprotein
b
mrna
transcript
edit
occur
intestin
much
simpler
methodolog
develop
measur
hdl
nonhdl
lipoprotein
mice
base
precipit
enzymat
analysi
phosphotungst
magnesium
salt
ad
serum
plasma
lipoprotein
except
hdl
precipit
remov
remain
solut
test
cholesterol
describ
previous
nonhdlcholesterol
compon
calcul
subtract
hdlcholesterol
total
cholesterol
nonprecipit
sampl
sehayek
et
al
strain
develop
elev
cholesterol
level
associ
increas
nonhdl
level
consum
high
fat
diet
breslow
c
mous
apoprotein
commerci
antibodi
mous
apoprotein
apoprotein
avail
elisa
describ
measur
apoprotein
plasma
hdl
fraction
plasma
danski
et
al
plasma
apoprotein
level
also
measur
multiplex
analysi
assay
mous
apoprotein
j
apoj
clusterin
also
describ
navab
et
al
apoj
ubiquit
glycoprotein
postul
multipl
function
associ
hdl
amyloidassoci
protein
associ
amyloid
plaqu
format
alzheim
diseas
human
analyt
associ
lipid
metabol
atherosclerosi
mice
elisa
kit
commerci
avail
quantit
mani
mous
coagul
protein
includ
fibrinogen
factor
vii
ddimer
tissu
factor
von
willebrand
factor
antigen
elisa
kit
also
avail
quantifi
mani
murin
product
arachidon
acid
metabol
includ
hete
reagent
elisa
kit
multiplex
assay
avail
murin
inflammatori
cytokin
chemokin
see
cytokin
chemokin
section
well
monocyt
coloni
stimul
factor
danski
et
al
describ
assay
quantit
murin
aryl
esteras
paraoxonas
tabl
list
mous
enzym
involv
lipid
metabol
refer
describ
measur
innat
adapt
immun
respons
extens
studi
see
volum
seri
therefor
attempt
describ
featur
mous
immun
detail
reader
direct
volum
molecular
cellular
immunolog
mous
gener
overview
chapter
follow
detail
descript
section
describ
grow
number
quantifi
solubl
serum
protein
lipid
associ
immun
inflamm
mous
see
tabl
furthermor
addit
immunodefici
autoimmun
allergi
investig
atherosclerosi
obes
diabet
cancer
well
infecti
diseas
immunolog
inflammatori
compon
immunoglobulin
ig
human
mous
immunoglobulin
ig
molecul
compos
four
polypeptid
chain
two
lower
molecular
weight
call
light
l
chain
two
higher
molecular
weight
call
heavi
h
chain
disulfid
bond
link
one
l
chain
one
h
chain
two
h
chain
immunoglobulin
h
chain
compos
four
five
domain
includ
ntermin
variabl
region
domain
four
constantregion
domain
addit
structur
differ
constantregion
domain
heavi
chain
use
classifi
five
differ
class
immunoglobulin
igm
igg
iga
ige
igd
l
chain
compos
two
domain
structur
differ
domain
use
classifi
l
chain
either
kappa
lambda
type
mous
serum
ig
kappa
l
chain
individu
antibodi
secret
b
cell
plasma
cell
make
singl
ig
molecul
compos
two
ident
h
chain
two
ident
l
chain
mice
make
four
subtyp
igg
certain
strain
sjl
nod
make
rather
make
novel
igg
subtyp
mice
exact
homologu
human
subtyp
mesta
hugh
prenat
transplacent
transfer
matern
ig
well
postnat
transfer
across
intestin
epithelium
limit
subclass
immunoglobulin
mediat
neonat
fc
receptor
fcrn
locat
placenta
intestin
brush
border
proxim
small
intestin
bankert
mazzaferro
mous
fix
complement
classic
pathway
igg
fix
complement
altern
pathway
ige
homocytotrop
antibodi
capabl
bind
receptor
mast
cell
basophil
mediat
immedi
hypersensit
reaction
although
igg
ige
circul
mous
monom
igm
circul
pentam
iga
circul
polymer
molecul
normal
littl
igd
detect
serum
serum
level
igm
iga
igg
ige
influenc
rate
synthesi
rate
catabol
like
human
rate
igg
catabol
mice
directli
proport
serum
concentr
subclass
averag
halflif
murin
igg
day
catabol
rate
iga
independ
serum
concentr
mice
synthes
mgkgday
total
ig
although
depend
strain
level
antigen
stimul
certain
strain
propens
develop
specif
thelper
th
cell
subclass
respons
antigen
stimul
strain
refer
princip
phenotyp
typic
lymphocyt
modul
immun
respons
cytokin
secret
secret
ifni
lymphotoxin
gener
refer
favor
respons
immun
virus
intracellular
pathogen
secret
refer
enhanc
humor
immun
suppress
cell
mediat
immun
confront
antigen
balbc
mice
exhibit
respons
mice
exhibit
thldomin
respons
particip
immunoglobulin
antibodi
class
switch
see
volum
chapter
consequ
strain
model
choic
investig
allerg
inflamm
produc
higher
concentr
induc
immunoglobulin
class
ige
cban
strain
defici
abil
produc
igm
immunoglobulin
level
also
greatli
reduc
germfre
mice
offspr
mice
zincdefici
diet
mice
proteindefici
diet
quimbi
quantifi
variou
class
subclass
murin
ig
done
use
variou
immunoassay
includ
radial
immunodiffus
ria
enzym
immunoassay
ria
enzym
immunoassay
higher
degre
sensit
need
accur
quantit
level
ige
igd
murin
serum
enzym
immunoassay
becom
favor
assay
avoid
isotop
handl
dispos
report
concentr
normal
balbc
mice
mgml
mgml
mgml
mgml
iga
mgml
igm
mgml
ige
igd
less
mgml
bankert
mazzaferro
addit
mani
commerci
sourc
enzymelink
antibodi
suppli
reagent
instruct
develop
assay
measur
antigenspecif
antibodi
concentr
subclass
antibodi
complement
system
compos
chemic
immunolog
distinct
protein
capabl
interact
antibodi
certain
bacteri
product
cell
membran
brief
summari
system
describ
later
pleas
refer
two
recent
public
quimbi
turnberg
botto
detail
structur
function
aspect
protein
complement
system
role
complement
system
mous
immun
describ
volum
overview
seri
sequenti
activ
individu
complement
protein
inact
activ
substanc
dynam
event
call
complement
cascad
abil
first
compon
complement
bind
specif
site
heavi
chain
mous
activ
sequenc
reaction
lead
product
molecular
unit
capabl
lyse
target
cell
membran
establish
complement
system
primari
mediat
antibodyantigen
reaction
recent
find
suggest
pentraxin
creactiv
protein
crp
serum
amyloid
protein
sap
pentraxin
bind
complement
compon
clq
activ
classic
pathway
may
import
mechan
remov
apoptot
cell
might
otherwis
predispos
autoimmun
diseas
nauta
et
al
protein
complement
system
normal
present
circul
inact
molecul
although
complement
cascad
may
activ
four
separ
pathway
central
event
activ
yield
small
cz
chain
fragment
two
convertas
classic
lectin
pentraxin
pathway
altern
pathway
convertas
cleav
add
fragment
convertas
complex
form
convertas
cleavag
lead
membran
attack
complex
mac
common
activ
pathway
goldsbi
et
al
assemblag
mac
surfac
target
cell
lead
format
larg
channel
enabl
ion
small
molecul
diffus
lead
cell
death
activ
compon
complement
also
particip
chemotaxi
phagocytosi
cell
adhes
bcell
differenti
mani
notabl
differ
mice
human
regard
express
complement
compon
regul
cascad
activ
mice
activ
inact
form
circul
gene
chromosom
design
ss
slp
respect
mani
inbr
strain
synthes
activ
eg
aj
strain
due
posttransl
defect
therefor
gener
mac
strain
defici
product
eg
strain
complement
compon
exist
two
allel
form
mice
kda
molecular
weight
similarli
sever
notabl
differ
regul
complement
activ
regul
found
regul
complement
activ
rca
locu
murin
chromosom
human
restrict
assembl
stabil
convertas
enzym
mice
decay
acceler
factor
daf
encod
two
gene
howev
product
wide
dispers
tissu
membraneanchor
protein
inhibit
cleavag
acceler
decay
convertas
mice
major
regul
skin
kidney
ligand
crosslink
lead
lymphocyt
activ
membraneanchor
inhibitor
format
mac
prevent
bind
complex
defici
human
lead
hemolyt
anemia
mice
membran
cofactor
protein
mcp
major
cofactor
factor
human
caus
cleavag
deposit
selftissu
mous
mcp
express
testi
complement
receptor
encod
separategen
human
produc
altern
splice
singl
gene
mous
mice
complement
receptor
relat
geneprotein
crri
found
human
membraneanchor
inhibitor
major
regul
mous
kidney
function
mcp
human
crri
daf
activ
serv
cofactor
factor
enzymat
cleav
mous
wide
use
studi
biosynthesi
molecular
biolog
individu
compon
complement
gene
encod
compon
subcompon
receptor
inhibitor
identifi
mice
complement
compon
may
quantifi
assay
design
measur
function
properti
protein
antigen
properti
test
design
measur
antigen
properti
complement
gener
simpler
less
subject
error
less
expens
howev
disadvantag
measur
activ
inact
form
protein
therefor
may
correl
well
function
activ
protein
function
assay
measur
abil
entir
classic
altern
pathway
individu
compon
pathway
lyse
hemolyz
antibodyco
sensit
noncoat
altern
pathway
red
cell
suspens
agaros
gel
assay
precis
sensit
quimbi
antigen
assay
includ
radial
immunodiffus
electroimmunodiffus
rocket
electrophoresi
autom
immunoprecipit
cross
immunoelectrophoresi
recent
elisa
quimbi
elisa
kit
commerci
avail
quantifi
murin
c
lq
desarg
addit
antibodi
commerci
avail
well
murin
complement
compon
factor
b
may
quantifi
use
function
assay
quimbi
membranebound
complement
regul
crri
daf
detect
use
previous
publish
antibodi
lin
et
al
lin
et
al
principl
mediat
lectin
activ
pathway
mannosebind
lectin
mbl
bind
mannos
residu
surfac
microorgan
two
mblassoci
serin
proteas
masp
bind
mbl
complex
caus
cleavag
activ
mimic
activ
cl
commerci
avail
elisa
kit
avail
murin
mbla
mblc
quantit
activ
complement
includ
member
pentraxin
famili
mice
may
includ
crp
sap
although
concentr
crp
normal
mice
low
immunolog
reagent
avail
quantifi
pentraxin
mice
gentri
quimbi
circul
immun
complex
cic
multimolecular
substanc
compos
antigen
antibodi
activ
complement
compon
mice
igm
complement
activ
region
although
cic
may
form
follow
exposur
circul
foreign
antigen
associ
microorgan
also
common
manifest
spontan
autoimmun
diseas
seen
nzb
x
nzw
mrllpr
bxsb
krn
strain
cic
clear
circul
fcr
tissu
deposit
immun
complex
may
lead
vascul
cic
quantifi
mice
capit
bind
variou
complement
receptor
precipit
clq
polyethylen
glycol
immunoassay
commerci
avail
elisa
kit
commonli
employ
today
quimbi
inbr
strain
mutant
line
spontan
develop
autoimmun
diseas
suscept
autoimmun
diseas
induct
detail
mani
line
may
found
volum
chapter
l
l
seri
autoimmun
diseas
mice
includ
thyroid
rheumatoid
arthriti
syndrom
ss
hemolyt
anemia
lupu
erythematosu
type
diabet
mellitu
experiment
allerg
enceph
oophor
orchiti
gastriti
ulcer
coliti
polyendocrin
diseas
boyton
altmann
ravirajan
isenberg
sakaguchi
antibodi
direct
selfantigen
mous
quantifi
use
wide
rang
method
immunofluoresc
elisa
tabl
list
commerci
avail
elisa
kit
use
quantifi
murin
autoantibodi
antigen
target
associ
system
lupu
erythematosu
includ
cardiolipin
doublestrand
deoxyribonucl
acid
dsdna
singlestrand
deoxyribonucl
acid
ssdna
histon
glycoprotein
prolifer
cell
nuclear
antigen
pcna
neutrophil
cytoplasm
antibodi
canca
ribosom
p
smith
antigen
target
arthriti
includ
rheumatoid
factor
rf
collagen
type
collagen
type
ssdna
antibodi
insulin
glutam
acid
decarboxylas
seen
type
juvenil
diabet
mix
connect
tissu
diseas
character
antibodi
ribonuclearprotein
rnp
antibodi
myeloperoxidas
mpo
may
observ
vascul
mice
ss
develop
autoantibodi
ss
antigen
b
ssa
ssb
respect
panel
contain
autoantigen
avail
multiplex
assay
quantifi
murin
autoantibodi
interleukin
il
il
cytokin
secret
leukocyt
act
leukocyt
interleukin
classifi
base
secretori
cell
type
ie
monokin
vs
lymphokin
classifi
base
whether
primarili
involv
innat
tnft
ifnt
adapt
immun
commerci
avail
elisa
kit
avail
quantifi
murin
interleukin
demonstr
tabl
name
two
protein
illt
encod
separ
gene
along
receptor
antagonist
tnft
protein
modul
acut
inflamm
effect
pleotroph
involv
bone
remodel
insulin
secret
appetit
regul
fever
induct
neuron
develop
mani
other
secret
amino
acid
aa
procytokin
enzymat
cleav
bioactiv
segment
unlik
intact
procytokin
ct
also
bioactiv
within
cytoplasm
cell
surfac
anchor
cell
membran
via
mannos
glycosyl
residu
attach
membraneassoci
lectin
sequenc
identifi
mous
human
ili
gene
ident
mous
human
gene
third
gene
encod
receptor
antagonist
solubl
molecul
sequenc
homolog
illt
homolog
mous
illra
homolog
human
illra
two
receptor
type
ii
capabl
signal
transduct
illra
inhibit
action
illt
bind
form
also
describ
solubl
preferenti
bind
illra
signal
transduc
associ
protein
serv
modul
level
ili
illra
bind
cell
surfac
also
occur
solubl
receptor
recent
find
six
new
member
ligand
famili
human
revis
nomenclatur
ligand
fred
w
quimbi
richard
h
luong
receptor
famili
develop
sim
detail
may
found
volum
overview
chapter
seri
ii
lymphokin
secret
activ
thelper
cell
act
autocrin
fashion
induc
express
receptor
cell
result
tcell
prolifer
cogoligreut
et
al
also
act
paracrin
fashion
modul
activ
b
cell
natur
killer
nk
cell
lymphocyt
activ
killer
lak
cell
glycoprotein
amino
acid
human
homolog
mous
human
receptor
multisubunit
cellular
receptor
belong
class
cytokin
receptor
famili
hematopoietin
receptor
famili
ychain
ychain
interact
transduc
signal
ychain
share
receptor
iii
mice
respons
downstream
event
lead
differenti
activ
cell
also
induc
express
adhes
molecul
like
vcam
cytokin
chemokin
like
prime
mast
cell
basophil
lead
enhanc
activ
allerg
challeng
mueller
et
al
homolog
mous
human
molecul
low
speciesspecif
biolog
activ
induc
growth
progenitor
igm
product
cell
induc
class
switch
favor
product
iga
ige
eosinophil
induc
iga
igg
receptor
stimul
leukotrien
lt
paf
secret
addit
induc
eosinophil
growth
matur
receptor
consist
ligand
bind
txsubunit
nonligand
bind
common
signal
transduc
subunit
share
receptor
granulocytemonocyt
colonystimul
factor
gmcsf
sato
miyajima
vi
secret
wide
varieti
cell
includ
cell
b
cell
monocyt
fibroblast
hepatocyt
keratinocyt
astrocyt
endotheli
cell
broad
pleiotrop
effect
host
defens
acut
phase
respons
immun
respons
hematopoiesi
classifi
inflammatori
cytokin
base
helic
cytokin
structur
subunit
makeup
prototyp
member
famili
molecul
includ
leukemia
inhibitori
factor
lif
oncostatin
osm
ciliari
neurotroph
factor
cntf
cardiotrophin
mous
kda
contain
four
cystein
contain
oglycosyl
site
share
homolog
human
molecul
van
snick
receptor
two
subunit
nonsign
transduc
subunit
bind
low
affin
subunit
signal
transduc
subunit
subunit
bind
particip
highaffin
bind
solubl
chain
bind
complex
induc
express
attract
monocyt
area
inflamm
kaplanski
et
al
vii
previous
call
express
stromal
cell
especi
bone
marrow
thymu
promot
thymopoiesi
cell
differenti
prob
cell
preb
cell
aspinal
et
al
goldsbi
et
al
mous
amino
acid
sequenc
homolog
human
protein
exhibit
crossspeci
activ
viii
express
mous
howev
anoth
protein
kc
secret
mani
properti
human
chemokin
gro
known
bind
receptor
see
cytokin
chemokin
section
ix
inrelclevlclnio
ilio
prototyp
member
cytokin
famili
compris
fisp
amino
acid
protein
amino
acid
signal
sequenc
mous
human
two
intrachain
disulfid
bond
form
nondisulfid
link
homodim
mous
human
homolog
cytokin
inhibit
ifni
gmcsf
product
cell
addit
induc
tcell
chemotaxi
inhibit
tcell
apoptosi
particip
iga
class
switch
b
cell
induc
histamin
releas
mast
cell
promot
tnftx
gmcsf
product
nk
cell
inhibit
secret
neutrophil
chemokin
miplt
mipi
block
product
tnfct
neutrophil
immunosuppress
dendrit
cell
induc
differenti
subset
regulatori
cell
trl
grouz
cottrez
morel
et
al
x
also
known
adipogenesi
inhibitori
factor
agif
pleiotrop
cytokin
effect
overlap
member
cytokin
famili
fourhelix
bundl
fold
motif
bind
multimer
receptor
share
promiscu
signal
subunit
receptor
famili
chain
uniqu
bind
cytoplasm
domain
instead
bind
lead
homodimer
chain
activ
janu
kinas
stimul
prolifer
differenti
monocyt
megakaryocyt
caus
thrombopoiesi
also
activ
osteoclast
enhanc
bone
resorpt
decreas
new
bone
format
stimul
chondrocyt
synoviocyt
product
protect
small
intestin
epitheli
cell
chemotherapi
radiat
injuri
amelior
inflammatori
bowel
diseas
schwertschlag
et
al
inhibit
adipogenesi
regul
neuron
differenti
regul
tcell
function
enhanc
inhibit
cytokin
product
overexpress
lung
caus
airway
remodel
fibrosi
mononuclear
nodul
analog
clinic
pictur
chronic
asthma
also
requir
uterin
decidu
respons
robb
et
al
zheng
et
al
xi
also
known
natur
killer
cell
stimulatori
factor
nksf
heterodimer
cytokin
compos
subunit
kda
subunit
subunit
share
cytokin
similar
activ
macrophag
monocyt
dendrit
cell
produc
activ
tolllik
receptor
tlr
cell
bacteri
ligand
induc
product
nk
cell
intact
skew
balanc
th
subset
favor
cell
bind
receptor
compos
two
subunit
surfac
nk
cell
interact
bind
neg
feedback
regul
product
involv
regul
tlr
signal
phosphoinositid
pik
thu
central
involv
interfac
innat
adapt
immun
fukao
koyasu
ottenhoff
et
al
xit
along
member
cytokin
famili
involv
inflamm
mucu
product
tissu
remodel
fibrosi
singlechain
protein
share
amino
acid
sequenc
homolog
human
produc
activ
cell
mast
cell
nk
cell
promot
respons
includ
synthesi
ige
signal
mediat
receptor
consist
chain
anoth
bind
protein
strongli
inhibit
activ
goldsbi
et
al
mentinkkan
wynn
xiii
also
known
cytotox
lymphocyteassoci
produc
cell
pleiotrop
activ
amino
acid
residu
polypeptid
amino
acid
signal
sequenc
matur
polypeptid
amino
acid
disulfidelink
homodim
base
presenc
spatial
conserv
cystein
residu
famili
protein
six
famili
member
human
mice
aggarw
gurney
like
sever
famili
member
appear
modul
immun
function
produc
mous
cell
induc
granulocyt
colonystimul
factor
gcsf
fibroblast
keratinocyt
epitheli
cell
endotheli
cell
induc
surfac
express
prolifer
cell
differenti
marrow
progenitor
neutrophil
fossiez
et
al
ubiquit
distribut
receptor
type
transmembran
glycoprotein
amino
acid
length
xiv
nonglycosyl
polypeptid
lack
classic
signal
sequenc
structur
resembl
propeptid
undergo
proteolyt
cleavag
enzym
ice
anoth
caspas
produc
bioactiv
molecul
sequenc
homolog
mous
human
induc
product
cell
nk
cell
express
fa
ligand
fasl
varieti
type
activ
nf
induct
variou
chemokin
play
import
role
earli
antibacteri
host
respons
weijer
et
al
xv
induc
keratinocyt
differenti
prolifer
fourhelixbundl
cytokin
similar
structur
share
sequenc
homolog
murin
homolog
human
receptor
util
common
produc
cell
action
pleiotrop
seen
b
cell
cell
nk
cell
dendrit
cell
induc
apoptosi
rest
activ
b
cell
effect
counteract
activ
also
upregul
product
inhibit
ige
fact
inhibit
mani
activ
also
inhibit
dendrit
cell
differenti
enhanc
activ
activ
nk
cell
mediat
prolifer
expans
tcell
subset
induc
acut
phase
reactant
hepatocyt
reduc
product
mehta
et
al
recombin
antigen
antibodi
commerci
avail
murin
b
transform
growth
factor
superfamili
tgfsf
cytoin
member
tgf
famili
share
sequenc
homolog
tfgi
monomer
structur
consist
two
antiparallel
pair
form
flat
curv
surfac
separ
long
czhelix
disulfid
rich
core
characterist
cystein
knot
tgfsf
member
disulfidelink
homodim
howev
three
member
lack
seventh
conserv
cystein
residu
coval
homodim
member
tgf
includ
tgf
activin
inhibin
bone
morphogen
protein
bmp
growth
differenti
factor
gdf
glialderiv
neutroph
factor
gdnf
mtillerian
inhibit
substanc
mi
tgf
stimulatori
cell
mesenchym
origin
inhibitori
cell
epitheli
neuroectoderm
origin
murin
immun
system
tgf
mediat
immun
suppress
via
cell
least
case
suppress
effector
cell
involv
tgf
receptor
ii
cell
powri
von
boehmer
addit
tgf
known
inhibit
bcell
prolifer
promot
isotyp
switch
iga
oral
toler
respons
food
allergin
mediat
mucida
et
al
tgf
wide
rang
effect
cell
growth
differenti
malign
transform
letterio
murin
tgfi
may
quantifi
serum
plasma
use
commerci
avail
elisa
kit
antibodi
also
avail
specif
bind
murin
bmp
activin
activin
c
although
recommend
elisa
develop
c
tumor
necrosi
factor
superfamili
tnfsf
tnfrelat
ligand
share
mani
featur
high
amino
acid
sequenc
homolog
one
except
nerv
growth
factor
tnf
ligand
type
ii
tramsmembran
protein
extracellular
cterminu
contain
short
cytoplasm
segment
long
extracellular
region
tnf
fulli
secret
nonfunct
transmembran
segment
tnfsf
member
form
trimer
structur
monom
compos
strand
orient
twosheet
structur
receptor
tnfsf
ligand
also
belong
superfamili
tnfrsf
gruss
dower
character
type
transmembran
protein
amino
termini
outsid
cell
extracellular
cysteinerich
structur
motif
tnfrsf
member
exist
membran
solubl
form
commerci
avail
elisa
kit
match
antibodi
develop
assay
avail
quantifi
murin
receptor
ligand
tnfsf
discuss
section
tumor
necrosi
factorix
tnfix
tnftx
express
membran
glycoprotein
solubl
glycoprotein
gener
proteolyt
cleavag
via
tnfct
convert
enzym
tace
homotrim
cleavag
product
circul
mous
tnftx
sequenc
homolog
human
tnftx
express
wide
tissu
throughout
bodi
goetz
et
al
tnftx
strong
mediat
inflamm
immun
function
regul
growth
differenti
cytotox
mani
transform
cell
ii
iii
type
ii
transmembran
glycoprotein
proteolyt
cleav
solubl
form
full
biolog
activ
form
natur
trimer
structur
mous
share
sequenc
ident
human
cell
express
includ
b
cell
cell
monocyt
nk
cell
cell
toubi
shoenfeld
bind
complex
initi
signal
import
cell
prolifer
apoptosi
crosslinkag
b
cell
allow
transduc
tyrosin
kinas
lyn
syk
activ
phospholipas
c
dag
combin
cytokin
ligat
bcell
provid
second
signal
allow
differenti
b
cell
plasma
cell
goldsbi
et
al
iv
glycoprotein
sequenc
homolog
murin
human
molecul
express
monocyt
macrophag
b
cell
activ
cell
neutrophil
megakaryocyt
rest
cell
erythroid
precursor
eosinophil
ligat
induc
either
prolifer
apoptosi
v
fa
ligand
fasl
fasl
also
known
glycoprotein
cleavag
form
homotrim
activ
membran
form
mous
polymorph
fasl
also
exist
singl
amino
acid
substitut
posit
phe
leu
result
gener
lymphoprolif
diseas
gld
mutat
fasl
express
cell
adapt
innat
immun
system
well
cell
lung
intestin
sequenc
homolog
murin
fasl
human
fasl
lynch
et
al
ligat
fa
fasl
matur
cell
lead
activ
caspas
cascad
apoptosi
major
homeostat
mechan
regul
size
tcell
pool
elimin
cell
repeatedli
encount
selfantigen
goldsbi
et
al
vi
tnfrelateo
activationinduc
cytokin
tranc
tranc
also
call
rank
ligand
osteoprotegerin
ligand
opgl
osteoclast
differenti
factor
mous
human
share
sequenc
homolog
tranc
express
cell
tcell
rich
organ
thymu
lymph
node
vii
tnfreceeror
superfamili
tnfrsf
tnfrsf
member
mediat
cellular
effect
tnfsf
member
tnfri
tnfrii
bind
tnf
appear
tnf
complex
lt
complex
bind
tnfri
lt
receptor
associ
bcell
prolifer
express
mani
cell
throughout
bodi
mous
share
sequenc
homolog
human
howev
mous
molecul
amino
acid
extens
cytoplasm
tail
amino
acid
residu
amino
acid
delet
extracellular
region
compar
human
express
cell
ligat
result
product
murin
fa
lack
amino
acid
residu
found
human
share
sequenc
homolog
solubl
form
result
altern
gene
splice
circul
dimer
trimer
fa
express
stem
cell
fibroblast
nk
cell
keratinocyt
hepatocyt
b
cell
precursor
eosinophil
osteoprotegerin
opg
inhibit
action
osteoclast
secret
member
tnfrse
although
transmembran
segment
circul
disulfidelink
homodim
murin
troy
also
name
toxic
jnk
induc
taj
share
homolog
human
extracellular
domain
interferon
interferon
group
relat
distinct
protein
share
amino
acid
sequenc
homolog
member
type
interferon
famili
share
common
cell
surfac
receptor
compos
two
subunit
commerci
avail
elisa
kit
may
use
quantifi
murin
io
interferon
ifn
ifn
induc
wide
varieti
cell
includ
monocyt
macrophag
respons
viral
infect
one
known
induc
doubl
strand
ribonucl
acid
dsrna
induc
resist
viral
replic
bind
ifn
receptor
activ
jakstat
pathway
induc
sever
gene
one
gene
ribonucleas
degrad
viral
rna
bind
ifn
nk
cell
enhanc
lytic
activ
viral
infect
cell
ifn
secret
leukocyt
iii
inreturelcont
ifni
ifni
secret
cell
nk
cell
cytotox
cell
tc
activ
macrophag
secret
tnfct
express
class
ii
major
histocompat
complex
mhc
molecul
produc
antimicrobi
activ
ifni
secret
also
induc
antibodyclass
switch
support
phagocytosi
complement
fixat
ifni
promot
differenti
tc
precursor
involv
effector
respons
viral
infect
intracellular
pathogen
ifni
also
inhibit
expans
cell
ifni
secret
induc
success
stimul
cell
antigen
present
cell
e
chemo
chemokin
along
adhes
molecul
principl
control
leukocyt
migrat
directli
affect
leukocyt
retent
reloc
hematopoiesi
site
immun
defens
inflammatori
diseas
moser
et
al
chemokineinduc
signal
via
gprotein
coupl
cell
surfac
receptor
although
chemokin
secret
protein
two
chemokin
membran
bound
two
primari
subfamili
recogn
base
arrang
two
cystein
residu
either
locat
adjac
cc
separ
singl
amino
acid
cxc
two
minor
subfamili
includ
chemokin
singl
cystein
resid
chemokin
three
amino
acid
separ
cystein
residu
function
conserv
region
nterminu
member
mediat
receptor
bind
extracellular
matrix
fixat
bind
cell
surfac
glycosaminoglycan
mani
chemokin
design
name
given
time
identif
also
assign
name
base
structur
motif
cc
cxc
xc
follow
l
ligand
receptor
heterotrim
activ
gprotein
subunit
stimul
phospholipas
c
pik
csrc
tyrosin
kinas
moser
et
al
receptor
design
type
chemokin
bind
ie
cxc
cc
xc
follow
r
mice
lack
famili
chemokin
receptor
found
human
tabl
list
murin
chemokin
receptor
known
ligand
tabl
list
murin
chemokin
either
commerci
test
kit
match
antibodi
kit
develop
two
main
function
group
defin
chemokin
inflammatori
chemokin
recruit
effector
leukocyt
site
infect
inflamm
repair
homeostat
chemokin
control
navig
leukocyt
hematopoiesi
bone
marrow
thymu
control
home
cell
spleen
lymph
node
peyer
patch
adapt
immun
respons
control
immun
surveil
peripher
tissu
chemokin
particip
inflamm
homeostasi
call
dualfunct
chemokin
mani
dual
function
chemokin
highli
select
recruit
cell
chemokin
illdefin
function
regard
homeostasi
inflamm
particip
vital
activ
role
thrombosi
role
cxcl
gut
epitheli
cell
turnov
cliff
et
al
inflammatori
chemokin
thought
induc
varieti
stimuli
induc
express
broad
contrast
homeostat
chemokin
thought
constitut
express
except
induc
effect
lymphotoxin
tnf
bcell
attract
bcai
secondari
lymphoid
tissu
chemokin
slc
also
particip
inflamm
leukocyt
also
releas
sever
kind
proteas
degrad
chemokin
nterminu
result
loss
receptor
bind
antagonist
gener
enhanc
biolog
function
leukocyt
dipeptidyl
peptidas
iv
known
act
murin
sulphostin
inhibit
action
stimul
gcsf
granulopoiesi
abe
et
al
matrix
metalloproteas
mmp
enzym
degrad
extracellular
matrix
protein
includ
stromal
cell
deriv
tabl
list
murin
mmp
quantifi
commerci
avail
elisa
kit
addit
mmp
cathepsin
shown
modifi
chemokin
tabl
list
murin
chemokin
proteas
degrad
stimuli
induc
certain
chemokin
may
antagon
activ
chemokin
instanc
three
agonist
receptor
also
antagonist
receptor
agon
eotaxin
differenti
express
cell
chemokin
monokin
induc
ifni
ifninduc
ifninduc
tcell
chemoattract
modul
th
subpopul
allow
enter
tissu
site
favor
immun
polar
moser
et
al
tabl
summar
known
effect
murin
chemokin
chemokin
receptor
known
modul
mani
inflammatori
diseas
includ
autoimmun
diseas
becom
target
new
therapeut
chemokin
antagonist
metrant
shown
effect
inhibitor
allerg
airway
diseas
mice
likewis
defici
chemokin
receptor
mice
modifi
diseas
progress
atherosclerosi
autoimmun
also
prolong
allograft
surviv
mackay
addit
mani
viral
genom
known
encod
structur
gene
chemokin
antagonist
appear
princip
mechan
use
mani
virus
evad
host
immun
system
present
anoth
target
drug
intervent
viral
infect
final
pepducin
deriv
intracellular
loop
specif
inhibit
receptor
gprotein
signal
mice
prevent
fatal
sepsi
dissemin
intravascular
coagul
kaneid
et
al
certain
growth
factor
see
tabl
cytokin
activ
phospholipas
bind
cell
surfac
receptor
phospholipas
act
membran
phospholipid
releas
arachidon
acid
precursor
sever
eicosanoid
arachidon
acid
metabol
one
three
biochem
pathway
cyclooxygenas
cox
pathway
form
pg
thromboxan
lo
pathway
form
hete
leukotrien
lt
cytochrom
monooxygenas
pathway
form
epoxid
hete
cox
enzym
catalyz
first
step
synthesi
pg
convert
arachidon
acid
prostaglandin
h
pgh
chemic
unstabl
precursor
enzymat
nonenzymat
product
pgd
pge
pgfza
thromboxan
synthetas
convert
pgh
thromboxan
quickli
convert
thromboxan
b
vascular
tissu
pgh
convert
pgi
prostacyclin
prostacyclin
synthetas
natarajan
nadler
reimer
although
constitut
express
tissu
induc
bacteri
lipopolysaccharid
ili
illl
tnf
see
cytokin
chemokin
section
circul
pge
pgi
caus
vasodil
wherea
pgfza
txb
potent
vasoconstrictor
kidney
produc
vasodil
increas
renal
blood
flow
urinari
excret
sodium
renal
product
increas
txa
modul
platelet
aggreg
follow
platelet
adhes
releas
catecholamin
serotonin
adenosin
diphosph
enhanc
platelet
aggreg
pgi
potent
inhibitor
platelet
aggreg
increas
wherea
decreas
abil
red
cell
pass
capillari
pgfza
inhibit
activ
b
cell
product
il
chemokin
attract
monocyt
pgd
potent
induc
chemotaxi
th
cell
play
major
role
allerg
airway
diseas
vari
activ
vasodil
vascular
permeabl
leukocyt
migrat
pg
potent
modul
inflamm
addit
inhibit
mackay
rossi
et
al
niess
et
al
mackay
huang
xiang
yamaguchi
et
al
insulin
secret
releas
glucos
challeng
see
glucos
carbohydr
metabol
section
inhibit
lipolyt
effect
glucagon
adrenocorticotrop
hormon
epinephrin
see
lipid
metabol
section
inhibit
secret
corticosteron
prolactin
prl
gh
thyroid
stimul
hormon
tsh
lh
fact
pg
multitud
effect
associ
femal
reproduct
reimer
tabl
action
arachidon
acid
convert
acid
leukotrien
unstabl
metabol
hydrolas
cysteinyl
leukotrien
synthas
express
limit
neutrophil
eosinophil
monocyt
mast
cell
howev
hydrolas
express
erythrocyt
cell
platelet
airway
intestin
epitheli
cell
fibroblast
heart
kidney
adren
cortex
latter
cell
tissu
express
must
deliv
via
myeloid
cell
process
known
transcellular
biosynthesi
maclouf
receptor
identifi
either
wide
express
confin
myeloid
cell
cell
lung
cell
addit
attract
myeloid
cell
site
inflamm
potent
induc
effector
cell
chemotaxi
potent
mous
cell
chemotaxi
potent
rant
like
play
major
role
allerg
airway
diseas
luster
tager
addit
inform
murin
prostanoid
receptor
avail
recent
review
jala
haribabu
kobayashi
narumiya
arachidon
acid
metabolit
discuss
section
may
quantifi
use
commerci
avail
elisa
kit
see
tabl
e
enzym
ap
induc
enzym
serum
activ
increas
due
increas
synthesi
exact
physiolog
function
ap
known
thought
transport
metabolit
across
cell
membran
quantif
serum
ap
base
reaction
ap
suitabl
phosphoryl
substrat
suscept
ap
activ
speci
two
major
form
ap
mice
intestin
ap
lap
tissu
nonspecif
ap
tnap
unlik
domest
anim
speci
iap
activ
contribut
serum
ap
activ
addit
tnap
lap
locat
along
brushbord
enterocyt
intestin
ap
activ
shown
vari
fourfold
two
strain
swiss
mice
nayudu
moog
differ
activ
polygen
control
influenc
strainspecif
factor
milk
tnap
found
variou
tissu
locat
posttransl
modif
may
result
differ
isoenzym
hoshi
et
al
use
immunohistochemistri
local
isoenzym
mice
follow
locat
bone
tissu
specif
entir
cell
surfac
preosteoblast
basolater
cell
membran
osteoblast
cartilag
mostli
chondrocyt
prolif
hypertroph
zone
incisor
particularli
cell
stratum
intermedium
subodontoblast
layer
proxim
portion
secretori
ameloblast
basolater
portion
odontoblast
kidney
brush
border
proxim
renal
tubul
kidney
liver
cell
membran
biliari
canaliculi
placenta
trophoblast
serum
ap
activ
vari
due
type
assay
use
age
sex
strain
differ
ap
assay
vari
type
substrat
use
ph
reaction
incub
temperatur
reaction
affect
quantit
ap
activ
exampl
hausamen
techniqu
detect
renal
intestin
ap
activ
hepat
ap
activ
hausamen
et
al
loeb
et
al
frith
et
al
demonstr
serum
ap
activ
decreas
significantli
month
age
balbc
mice
sex
increas
old
month
old
mice
high
level
serum
ap
seen
juvenil
relat
increas
bone
ap
isoenzym
associ
osteoblast
activ
due
rapid
growth
picket
picket
show
serum
ap
activ
lower
male
femal
quantif
serum
ap
measur
total
ap
activ
sourc
therefor
elev
ap
activ
nonspecif
determin
tissu
dysfunct
depend
tissu
therefor
ap
isoenzym
involv
exampl
chang
serum
activ
ap
due
liver
diseas
occur
cholestasi
concurr
involv
mice
lack
gene
modifi
tnap
bone
isoenzym
suffer
skelet
hypominer
anderson
et
al
alt
cytoplasm
enzym
serum
activ
increas
due
leakag
across
damag
cytoplasm
membran
alt
also
known
glutam
pyruv
transaminas
gpt
revers
catalyz
convers
alanin
pyruv
quantif
serum
alt
base
reaction
alt
suitabl
substrat
alanin
mice
alt
found
highest
concentr
liver
although
activ
also
demonstr
intestin
kidney
heart
muscl
brain
clampitt
hart
despit
widespread
tissu
distribut
alt
mostli
use
analyt
assess
hepatocellular
damag
masaki
et
al
taieb
et
al
increas
serum
alt
activ
report
follow
infect
mous
hepat
viru
signific
increas
follow
infect
helicobact
hepaticu
mccathey
et
al
ast
cytoplasm
mitochondri
enzym
serum
activ
increas
due
leakag
across
damag
cytoplasm
mitochondri
membran
ast
also
known
glutam
oxaloacet
transaminas
got
revers
catalyz
convers
aspart
oxaloacet
quantif
serum
ast
base
reaction
ast
suitabl
substrat
aspart
mice
ast
found
varieti
tissu
includ
liver
skelet
muscl
cardiac
muscl
erythrocyt
blood
vessel
brain
intestin
kidney
lung
test
papadimitri
van
duijn
highest
specif
activ
ast
found
mous
cardiac
muscl
lowest
skelet
muscl
herzfeld
knox
liver
ast
found
mainli
periport
hepatocyt
base
histochem
studi
papadimitri
van
duijn
activ
lung
kidney
intestin
skelet
muscl
low
measur
techniqu
bergmey
bernt
loeb
et
al
demonstr
signific
ageassoci
increas
serum
ast
activ
two
inbr
two
hybrid
strain
although
wide
distribut
alt
mainli
use
assess
hepatocellular
damag
cardiac
muscl
damag
naraoka
et
al
ray
et
al
testicular
injuri
santo
et
al
alt
activ
use
indic
hepat
injuri
mice
infect
mous
hepat
viru
fassati
et
al
ldh
cytoplasm
enzym
serum
activ
increas
due
leakag
across
damag
cytoplasm
membran
ldh
revers
catalyz
convers
pyruv
lactat
quantif
serum
ldh
base
reaction
ldh
suitabl
substrat
pyruv
lactat
speci
ldh
mous
tetramer
enzym
consist
either
b
subunit
five
isoenzym
ldh
base
differ
subunit
b
composit
specif
isoenzym
distribut
depend
differenti
express
either
b
subunit
quimbi
instanc
embryon
murin
tissu
contain
subunit
express
earli
fetal
develop
embryo
matur
subunit
express
involv
b
subunit
differ
tissu
mean
birth
sexual
matur
tissu
contain
characterist
ldh
subunit
profil
adult
mice
heart
erythrocyt
contain
wherea
tissu
skelet
muscl
hepatocyt
fail
express
subunit
b
therefor
compos
predominantli
serum
ldh
activ
vari
due
age
sex
ldh
level
shown
higher
male
versu
femal
balbc
strain
frith
et
al
serum
ldh
level
increas
age
balbc
mice
sex
frith
et
al
serum
ldh
also
elev
fals
hemolysi
quantif
serum
ldh
measur
total
ldh
activ
sourc
howev
damag
particular
tissu
result
increas
activ
isoenzym
serum
gener
highest
activ
ldh
mous
skelet
muscl
decreas
activ
heart
liver
kidney
intestin
serum
activ
rise
within
h
inocul
mice
mous
hepat
viru
fassati
et
al
mice
infect
ldh
viru
ldv
exhibit
increas
serum
concentr
ldh
isocitr
dehydrogenas
malic
dehydrogenas
phosphohexas
isomeras
ast
notkin
along
ast
ck
ldh
consid
excel
marker
cardiac
injuri
naraoka
et
al
ray
et
al
otc
mitochondri
enzym
serum
activ
increas
due
leakag
across
damag
mitochondri
membran
otc
found
primarili
liver
mice
increas
serum
activ
reflect
sever
injuri
hepatocyt
abnorm
otc
activ
describ
mice
sparsefur
spfi
mutat
serv
model
common
inborn
error
urea
synthesi
human
assay
mous
otc
develop
monitor
activ
level
follow
gene
transfer
liver
transplant
batshaw
et
al
ye
et
al
ck
cytoplasm
mitochondri
enzym
serum
activ
increas
due
leakag
across
damag
cytoplasm
mitochondri
membran
ck
revers
catalyz
phosphoryl
adenosin
diphosph
adp
ate
use
creatin
phosphat
donor
phosphat
group
quantif
serum
ck
base
reaction
ck
suitabl
substrat
creatin
phosphat
speci
cytoplasm
ck
dimer
enzym
consist
either
b
subunit
three
isoenzym
ck
base
differ
subunit
b
composit
bb
mb
mm
brain
contain
skelet
muscl
contain
mm
cardiac
muscl
contain
mb
quimbi
mous
greatest
ck
activ
found
skelet
muscl
much
less
activ
found
heart
brain
mitochondri
ck
ckmt
found
mitochondria
mani
tissu
serum
ck
activ
affect
age
sex
method
collect
anesthesia
patrick
et
al
found
compar
jugular
vein
collect
cardiac
punctur
associ
lower
ck
activ
level
serum
ck
activ
report
balccann
mice
mice
vari
age
sex
sub
et
al
serum
ck
activ
use
specif
marker
enzym
muscl
injuri
ck
central
nervou
tissu
cross
bloodbrain
barrier
sub
et
al
compar
normal
mice
heterozyg
male
homozyg
femal
mice
carri
mdx
mutant
dystrophin
allel
found
homozyg
femal
increas
heterozyg
male
mdxi
fold
increas
plasma
ck
compar
wildtyp
mice
plasma
ck
level
correl
skelet
muscl
necrosi
dystroph
mice
mice
engin
lack
cytoplasm
ck
ckmt
mitochondria
heart
skelet
muscl
doubl
ko
higher
adp
concentr
compar
wildtyp
anim
suggest
higher
concentr
contribut
control
reduc
cytosol
atp
free
energi
potenti
seen
doubl
ko
aldolas
cytosol
enzym
alter
distribut
solubl
particul
form
accord
metabol
statu
tissu
adult
mice
nine
aldolas
isoenzym
known
occur
tissu
signific
activ
muscl
brain
liver
kidney
spleen
mous
liver
aldolas
togeth
fructokinas
triokinas
metabol
fructos
hagopian
et
al
everett
harrison
report
appar
advantag
mice
measur
aldolas
enzym
known
specif
liver
muscl
activ
sdh
cytoplasm
mitochondri
enzym
serum
activ
increas
due
leakag
across
damag
cytoplasm
mitochondri
membran
sdh
also
known
iditol
dehydrogenas
idh
revers
catalyz
convers
fructos
sorbitol
quantif
serum
sdh
base
reaction
sdh
suitabl
substrat
fructos
sdh
locat
primarili
liver
kidney
semin
vesicl
activ
sdh
usual
low
serum
rise
hepat
injuri
howev
labil
natur
sdh
handl
make
less
suitabl
overal
indic
hepat
dysfunct
compar
liverspecif
enzym
ast
mice
gene
sdh
knock
use
studi
role
sorbitol
accumul
diabet
albuminuria
ii
et
al
amylas
cytoplasm
enzym
serum
activ
increas
due
leakag
across
damag
cytoplasm
membran
amylas
hydrolyz
complex
carbohydr
form
maltos
glucos
presenc
free
calcium
ion
quantif
serum
amylas
base
reaction
amylas
suitabl
substrat
starch
similar
human
pig
dog
cat
cattl
hors
express
amylas
mice
relat
two
distinct
close
link
loci
meisler
et
al
salivari
amylas
gene
product
salivari
appear
singl
enzym
pancreat
amylas
gene
product
base
electrophoret
studi
inbr
mice
appear
four
isoenzym
class
b
similar
domest
anim
speci
pancreat
amylas
filter
glomerulu
unlik
domest
speci
pancreat
amylas
resorb
renal
tubular
epitheli
cell
excret
rapidli
urin
therefor
normal
serum
amylas
activ
mice
consist
mainli
salivari
amylas
mackenzi
messer
despit
elev
serum
amylas
activ
usual
consid
reliabl
marker
pancreat
mice
nathan
et
al
ross
et
al
report
twoto
threefold
increas
serum
amylas
activ
mice
infect
coxsackieviru
salivari
pancreat
trophism
alter
activ
specif
pancreat
isoenzym
shown
streptozotocininduc
diabet
mice
quimbi
two
pancreat
lipas
isoenzym
mice
serum
lipas
activ
use
monitor
ceruleaninduc
acut
pancreat
mice
cuzzocrea
et
al
recent
new
colipasedepend
lipas
describ
suckl
mice
dagostino
low
enzym
measur
serum
normal
mice
use
simpl
onestep
kinet
method
dooley
racich
refer
rang
sd
record
mice
thought
proven
good
indic
hepat
injuri
clampitt
hart
glutam
dehydrogenas
gdh
measur
tissu
serum
mice
gdh
known
play
key
role
insulin
secret
carobbio
et
al
activ
gdh
fivefold
greater
liver
kidney
brain
author
specul
measur
serum
would
sensit
indic
hepat
cell
injuri
serum
gdh
activ
also
elev
mice
calor
restrict
hagopian
et
al
corticosteron
major
glucocorticoid
secret
adren
cortex
mice
function
regul
carbohydr
protein
fat
metabol
modifi
host
respons
stress
male
mous
welldefin
diurnal
concentr
pattern
maximum
concentr
ktgdl
start
dark
cycl
minimum
concentr
btgdl
shortli
end
dark
cycl
ottenwel
et
al
contrast
femal
mice
minimum
concentr
ktgdl
begin
dark
cycl
maximum
tgdl
well
dark
period
scheve
et
al
length
dark
cycl
differ
studi
may
measur
use
radioimmunoassay
elisa
fluorometr
assay
mous
serum
plasma
corticosteron
circul
free
protein
bound
form
mous
greater
circul
bound
cortisolbind
globulin
cbg
albumin
diurnal
variat
corticosteron
level
parallel
diurnal
pattern
cbg
urinari
salivari
corticosteron
deriv
free
plasma
fraction
corticosteron
synthesi
secret
may
influenc
mani
drug
woodman
measur
corticosteron
unrestrain
mice
use
indwel
cathet
elucid
necess
elimin
stress
accur
interpret
data
macleod
shapiro
handl
crowd
laboratori
mice
caus
elev
corticosteron
balcomb
et
al
fullwood
et
al
obob
mice
elev
corticosteron
level
increas
markedli
week
age
preced
elev
serum
glucos
garthwait
et
al
lean
control
lower
serum
concentr
corticosteron
declin
week
age
food
restrict
ad
libitum
profoundli
affect
diurnal
increas
plasma
corticosteron
mice
hour
pm
daili
maximum
studi
food
restrict
balbc
mice
corticosteron
compar
control
mice
also
significantli
reduc
thymic
weight
inflamm
respons
inject
carrageenan
subcutan
author
report
magnitud
carrageenaninduc
inflamm
fluctuat
diurnal
trough
coincid
peak
corticosteron
level
klebanov
et
al
corticosteron
synthes
respons
acth
made
anterior
pituitari
acth
releas
episod
fix
interv
involv
steroid
feedback
acth
concentr
peak
earli
even
mice
revers
revers
light
cycl
acth
highli
conserv
mous
acth
differ
human
two
amino
acid
residu
ria
may
use
measur
acth
mous
daili
level
vari
ngml
demonstr
rhythmic
cycl
sampl
must
collect
interv
commerci
elisa
kit
acth
also
avail
quimbi
ko
mice
incap
synthes
corticotrophin
releas
hormon
acth
may
requir
corticosteron
supplement
drink
water
particularli
suscept
hypoglycemia
fast
fetus
homozyg
ko
crh
null
mother
must
supplement
gestat
day
wean
mgml
corticosteron
drink
water
mugila
et
al
oxytocin
gene
ko
mice
respond
psychogen
stressor
anxietyrel
behavior
corticosteron
product
amico
et
al
lh
promot
follicular
develop
increas
estradiol
secret
preovulatori
follicl
caus
follicular
ruptur
convert
preovulatori
follicl
corpu
luteum
increas
progesteron
product
corpu
luteum
male
increas
product
testosteron
leydig
cell
woodman
lh
glycoprotein
compos
tand
chain
amino
acid
sequenc
tchain
ident
folliclestimul
hormon
fsh
howev
lchain
specif
confer
receptor
bind
properti
hormon
homolog
ria
rat
lh
use
antisera
rat
lh
purifi
rat
lh
employ
measur
lh
mice
quimbi
lh
folliclestimul
hormon
fsh
secret
anterior
pituitari
cell
respons
stimul
gonadotrophinreleas
hormon
gnrh
synthes
hypothalamu
gnrh
ident
mous
human
differenti
stimulatori
effect
gonadotrop
produc
fsh
lh
control
gnrh
puls
frequenc
pulsatil
secret
lh
lead
great
variat
blood
concentr
femal
mice
increas
basal
lh
level
afternoon
proestru
studi
compar
young
cycl
femal
mice
old
femal
cycl
flurkey
et
al
found
lower
lh
level
older
group
rapid
rise
lh
among
younger
cycl
mice
author
found
reproduct
failur
male
mice
correl
loss
episod
releas
lh
femal
homozyg
ko
mice
lack
gene
immedi
earli
transcript
factor
ngfia
infertil
secondari
lh
defici
although
ovari
mice
similar
number
follicl
lack
corpora
lutea
lee
et
al
basal
level
serum
progesteron
lower
ngfia
femal
ngml
compar
wild
type
ngml
wherea
serum
estradiol
level
similar
defici
pgml
wildtyp
pgml
mice
decreas
amount
mrna
encod
lh
fsh
observ
ngfiadefici
mice
chang
observ
mrna
level
prl
gnrh
receptor
defici
wildtyp
mice
ovariectomi
normal
remov
gonad
feedback
inhibit
allow
increas
amount
lh
fsh
pituitari
howev
ovariectomi
ngfia
defici
femal
mice
lead
increas
fsh
homozyg
ngfia
defici
male
make
lower
amount
lh
compar
wildtyp
male
made
significantli
lh
ngfiadefici
femal
level
lh
male
appear
suffici
fertil
normal
serum
testosteron
level
result
suggest
ngfia
act
synergist
transcript
factor
regul
promot
lh
gene
express
simultan
activ
ngfia
gnrh
appear
confer
specif
lh
synthesi
femal
transgen
mice
overexpress
lh
anovulatori
develop
granulosa
cell
tumor
undergo
precoci
puberti
mann
et
al
excel
review
detail
use
transgen
ko
mice
elucid
secret
function
lh
publish
bum
matzuk
huhtaniemi
et
al
well
murphi
fsh
stimul
growth
matur
ovarian
follicl
femal
promot
latter
stage
spermatogenesi
male
act
princip
sertoli
cell
seminifer
tubul
testi
induc
secret
androgenbind
protein
inhibin
femal
fsh
lh
distinct
secretori
pattern
synchron
estrou
cycl
mous
estrou
cycl
period
addit
estrou
cycl
depend
rhythm
lh
fsh
ultradian
puls
show
circadian
period
highest
level
occur
dark
period
light
cycl
testosteron
estrogen
progesteron
provid
feedback
regul
lh
fsh
secret
woodman
rat
mice
share
consider
sequenc
homolog
fsh
chain
rat
ria
kit
nation
institut
diabet
digest
kidney
diseas
niddk
use
measur
fsh
mous
dalterio
et
al
mous
specif
ria
commerci
avail
cycl
femal
mice
plasma
level
fsh
increas
ngml
proestru
ngml
estru
although
bronson
desjardin
found
age
associ
decreas
serum
lh
testosteron
male
cbf
mice
experienc
decreas
sperm
product
similar
decreas
observ
fsh
concentr
signific
differ
twofold
increas
fsh
level
seen
among
young
versu
old
male
follow
castrat
appear
differ
result
obtain
young
versu
old
rat
finch
et
al
regul
function
fsh
studi
transgen
ko
mice
cook
saunder
well
murphi
testosteron
promot
spermatogenesi
provid
feedback
regul
gonadotrophin
synthesi
action
epididymi
protein
necessari
spermatozo
matur
synthes
dihydrotestosteron
dht
promot
growth
differenti
accessori
sex
organ
depaolo
masoro
addit
effect
reproduct
organ
testosteron
dht
physiolog
function
central
nervou
system
cardiac
tissu
liver
mous
testosteron
stimul
growth
kidney
synthesi
erythropoietin
woodman
lh
stimul
synthesi
testosteron
cholesterol
interstiti
leydig
cell
testi
target
tissu
enzym
convert
testosteron
dht
fetal
test
leydig
cell
first
becom
identifi
rise
testosteron
mammalian
speci
leydig
cell
disappear
testosteron
level
fall
gestat
howev
mous
except
leydig
cell
undergo
regress
postnat
aoki
testosteron
dht
circul
free
protein
bound
form
ninetyeight
percent
total
testosteron
bound
protein
mainli
albumin
mice
unlik
human
dog
monkey
cat
circul
sex
hormonebind
globulin
mice
puls
releas
pattern
may
seen
within
diurnal
rhythm
testosteron
testosteron
measur
mice
use
ria
elisa
plasma
testosteron
found
chang
averag
lifespan
mice
finch
et
al
contrast
mice
wistar
longevan
rat
human
experi
greater
decreas
testosteron
midlif
bronson
desjardin
contrast
testosteron
level
older
mice
castrationinduc
elev
lh
impair
mice
compar
mice
androgen
receptor
ko
mice
describ
cook
saunder
estradiol
granulosa
cell
matur
graafian
follicl
main
sourc
mammal
fsh
stimul
activ
aromatas
follicl
respons
convers
androgen
e
also
synthes
testi
adren
liver
skin
although
much
lower
amount
ovari
provid
neg
feedback
control
lh
secret
stimul
prl
secret
mice
e
promot
growth
develop
femal
reproduct
tract
extern
genitalia
ductal
system
mammari
gland
addit
e
sensit
follicl
fsh
e
measur
mice
use
ria
elisa
high
circul
level
e
preced
preovulatori
surg
lh
ryan
schwartz
report
basal
level
e
mice
pgml
holinka
et
al
studi
circul
level
progesteron
estradiol
young
old
femal
mice
gestat
found
old
multipar
femal
delay
reduc
preparturit
rise
plasma
e
compar
young
femal
preparturit
e
thought
regul
uterin
progesteron
level
declin
e
seen
older
femal
coupl
elev
progesteron
may
delay
onset
labor
lead
prolong
gestat
sex
steroid
hormon
e
bind
receptor
induc
conform
chang
allow
complex
bind
dna
respons
element
nuclear
target
gene
associ
coactiv
transcript
factor
form
activ
transcript
complex
complex
respons
initi
transcript
target
gene
one
coactiv
associ
activ
transcript
complex
involv
sex
hormon
steroid
receptor
better
understand
physiolog
role
sex
hormonereceptor
bind
ko
mice
defici
creat
xu
et
al
defici
male
mice
reduct
testosteronestimul
prostat
growth
small
test
compar
wildtyp
mice
defici
femal
halfnorm
uterin
growth
respons
exogen
e
partial
ductal
growth
respons
mammari
gland
follow
exogen
e
progesteron
serum
concentr
e
testosteron
elev
time
wildtyp
level
indic
abnorm
endocrin
feedback
control
system
although
shown
clearli
necessari
optim
sex
hormoneinduc
cellular
activ
lesion
creat
ko
mous
nearli
profound
seen
mice
disrupt
e
receptor
korach
et
al
mice
gene
e
receptor
aromatas
knock
describ
simpson
et
al
synthes
corpu
luteum
implant
corpu
luteum
placenta
follow
implant
progesteron
necessari
prepar
uteru
implant
maintain
pregnanc
addit
small
amount
progesteron
synthes
adren
gland
activ
corpu
luteum
secret
progesteron
requir
lh
prl
progesteron
provid
neg
feedback
control
lh
mice
progesteron
measur
use
ria
elisa
cycl
mice
level
progesteron
increas
ngml
proestru
return
back
baselin
estru
flurkey
et
al
compar
plasma
level
lh
progesteron
prl
cycl
young
old
femal
mice
show
agerel
deficit
preovulatori
level
three
hormon
lh
elev
ascend
descend
portion
preovulatori
surg
smaller
slower
rise
lh
ascend
phase
surg
correl
decreas
progesteron
older
femal
correl
lh
progesteron
level
length
estru
cycl
holinka
et
al
observ
chang
plasma
progesteron
level
young
old
femal
mice
gestat
older
mother
much
slower
declin
circul
progesteron
younger
mother
gestat
day
major
decreas
plasma
progesteron
thought
essenti
onset
uterin
contract
parturit
mice
author
hypothes
attenu
declin
older
mother
may
account
prolong
gestat
surgimoto
et
al
engin
mice
lack
pgfzareceptor
fp
found
defici
femal
mice
normal
estrou
cycl
ovul
fertil
implant
undergo
parturit
pregnant
femal
character
declin
preparturit
progesteron
level
due
delay
luteolysi
failur
develop
labor
close
examin
reveal
near
term
express
oxytocin
receptor
uteru
fpdefici
mice
ovari
fpdefici
pregnant
femal
remov
day
pregnanc
progesteron
level
fell
uterin
oxytocin
receptor
express
pup
born
aliv
within
h
studi
demonstr
role
initi
luteolysi
result
immedi
declin
progesteron
level
subsequ
induct
oxytocin
receptor
activ
bound
oxytocin
initi
labor
feasibl
ageassoci
prolong
gestat
old
femal
mice
may
involv
defect
pgfz
induc
luteolysi
mechan
induct
labor
also
explain
wellknown
observ
aspirinlik
drug
inhibit
cox
metabol
may
delay
parturit
women
prl
singlechain
polypeptid
princip
made
pituitari
gland
may
also
found
brain
thymu
spleen
lymph
node
mammari
gland
myometrium
sweat
gland
lacrim
gland
bone
marrow
function
attribut
prl
involv
reproduct
lactat
growth
develop
endocrinolog
metabol
brain
behavior
immunomodul
electrolyt
balanc
mediat
effect
endocrin
paracrin
autocrin
mechan
mice
prl
major
import
mainten
structur
life
span
function
corpora
lutea
develop
mainten
mammari
gland
lactat
howev
prlreceptor
ko
male
major
defect
fertil
prl
play
role
anxietyrel
behavior
bone
develop
abdomin
fat
deposit
sex
kelli
et
al
role
immun
function
controversi
although
appear
modul
immun
time
stress
dorshkind
horseman
prl
mediat
effect
bind
prl
receptor
prlr
mice
two
major
form
prlr
creat
via
altern
splice
singl
gene
prlr
member
class
cytokin
receptor
superfamili
although
function
prl
mediat
unmodifi
peptid
posttransl
modif
allow
variant
prl
bind
receptor
elicit
transcript
gene
necessari
tissu
specif
chang
harri
et
al
prl
secret
inhibitori
control
dopamin
among
secretagogu
thyrotropinreleas
hormon
trh
vasoact
intestin
peptid
gastrin
serotonin
endorphin
oxytocin
angiotensin
ii
gnrh
arginin
vasopressin
prl
mice
quantifi
use
ria
use
nih
refer
standard
male
mice
measur
light
phase
ngml
wherea
rang
dark
phase
ngml
depaolo
masoro
oxytocin
nonapeptid
synthes
prohormon
neuron
whose
bodi
locat
supraopt
paraventricular
nuclei
base
hypothalamu
synthes
prohormon
packag
neurosecretori
granul
transport
axon
neuron
transport
synthes
oxytocin
par
nervosa
pituitari
gland
transport
molecul
cleav
yield
carrier
protein
neurophysin
l
lkda
oxytocin
primari
stimulu
oxytocin
releas
mechan
stimul
mammari
gland
distent
reproduct
tract
reimer
singl
oxytocin
receptor
otr
investig
use
ko
mice
shown
oxytocin
requir
milk
let
mammari
gland
well
postpartum
alveolar
prolifer
male
oxytocin
requir
normal
spermiat
sperm
transfer
gender
oxytocin
help
control
normal
blood
pressur
salt
intak
ko
display
reduc
aggress
strike
deficit
abil
recogn
previous
encount
mous
young
gainer
oxytocin
may
quantifi
mice
use
commerci
avail
elisa
kit
speciesspecif
ria
valu
one
recent
public
show
plasma
oxytocin
pgml
male
mice
avp
synthes
releas
neuron
previous
describ
oxytocin
although
two
secretori
granul
rare
coloc
neuron
carrier
protein
avp
neurophysin
ii
avp
releas
neuron
secretori
granul
electr
signal
osmoreceptor
measur
osmolar
extracellular
fluid
action
potenti
gener
receptor
caus
calcium
influx
axon
termin
exocytosi
ave
avp
transport
blood
kidney
bind
receptor
distal
segment
nephron
collect
duct
lead
increas
resorpt
water
reimer
three
avp
receptor
v
l
ar
vlbr
gprotein
coupl
receptor
nonsens
mutat
avp
gene
seen
brattleboro
rat
kd
mice
develop
neurohypophysi
central
diabet
insipidu
mice
knock
develop
nephrogen
diabet
insipidu
character
polyuria
polydipsia
failur
concentr
urin
ar
gene
knock
mice
develop
enhanc
prolifer
splenic
b
cell
enhanc
product
thymicdepend
antigen
v
lbr
knock
mice
display
mark
reduct
social
aggress
deficit
social
recognit
young
gainer
avp
measur
ria
elisa
report
valu
normal
male
mice
pgml
plasma
tsh
glycoprotein
made
anterior
pituitari
gland
stimul
thyrotropinreleas
hormon
trh
trh
made
hypothalamu
tsh
secret
pulsatil
manner
similar
acth
tsh
secret
regul
triiodothyronin
act
hypothalamu
inhibit
secret
trh
act
pituitari
gland
inhibit
tsh
synthesi
reimer
tsh
play
role
stimul
thyroid
gland
produc
thyroxin
influenc
outcom
tcell
develop
thymu
intestin
addit
thyroid
gland
tsh
receptor
found
mani
differ
popul
hematopoiet
cell
bone
marrow
subset
dendrit
cell
monocyt
lymphocyt
spleen
lymph
node
klein
scofield
et
al
ko
mice
creat
gene
trh
well
murphi
yamada
et
al
tsh
receptor
biesiada
et
al
delet
addit
spontan
mutat
pitl
gene
lead
defici
gh
prl
tsh
yeap
leedman
tsh
measur
ria
refer
rang
establish
around
umg
refer
standard
ngml
depaolo
masoro
thyroxin
triiodothyronin
synthes
entir
thyroid
gland
wherea
produc
primarili
convers
extrathyroid
tissu
thyroid
thyroglobulin
synthes
store
later
hydrolyz
form
tyrosin
residu
held
peptid
linkag
within
thyroglobulin
first
iodin
later
iodotyrosin
chemic
coupl
form
hormon
activ
product
depend
adequ
suppli
iodin
circul
blood
primarili
bound
albumin
mglobulin
howev
mous
transthyretin
bind
approxim
activ
thyroid
hormon
blood
made
monodeiodin
outer
ring
varieti
tissu
certain
drug
food
depriv
ill
effect
monodeiodinas
activ
reimer
action
mediat
via
two
receptor
trx
tr
act
hormoneinduc
transcript
factor
belong
larg
superfamili
nuclear
hormon
receptor
includ
steroid
hormon
vitamin
retino
acid
peroxisom
prolifer
receptor
yen
mous
human
tr
tr
encod
nine
mrna
isoform
altern
splice
four
isoform
tri
tr
tri
express
protein
trc
ko
mice
lack
product
tr
locu
fertil
normal
basal
thyroid
statu
increas
sensit
thyroid
hormon
pituitari
liver
follow
provoc
test
increas
dose
trx
disrupt
first
code
exon
trx
locu
prevent
transcript
tri
mrna
trai
pup
die
shortli
wean
unless
supplement
first
month
life
develop
normal
thyroxin
level
howev
gender
infertil
overexpress
tri
hypothyroid
inappropri
normal
tsh
level
exhibit
sign
hyperthyroid
increas
heart
rate
weight
loss
elev
bodi
temperatur
tr
lack
tr
isoform
display
resist
thyroid
hormon
demonstr
key
role
tr
setpoint
control
pituitarythyroid
feedback
axi
tr
ko
mice
resist
thyroid
hormon
elev
tsh
defect
tsh
suppress
sever
doubl
ko
tr
tri
develop
profound
resist
target
mutant
help
elucid
full
function
thyroid
hormon
involv
bone
format
miner
abnorm
develop
skelet
muscl
disrupt
develop
cone
retina
abnorm
auditori
system
cochlear
vestibular
structur
delay
small
intestin
develop
impair
thermogenesi
alter
develop
central
nervou
system
immun
system
oshea
william
total
measur
ria
mice
refer
rang
vari
greatli
strain
age
although
activ
hormon
serum
level
low
less
reliabl
indic
thyroid
statu
total
rang
swiss
webster
icr
mice
jagml
respect
total
level
rang
ml
sw
icr
stock
depaolo
masoro
mani
factor
includ
autoantibodi
known
interfer
thyroid
hormon
assay
despr
grant
reimer
parathyroid
hormon
pth
pth
synthes
chief
cell
parathyroid
gland
secret
amino
acid
peptid
circul
level
ioniz
calcium
induc
synthesi
pth
low
calcium
stimul
pth
synthesi
high
calcium
inhibit
secret
primari
function
pth
control
calcium
concentr
extracellular
fluid
prevent
hypocalcemia
increas
calcium
resorpt
bone
glomerular
filtrat
intestin
reimer
pth
mediat
effect
via
gprotein
coupl
receptor
interestingli
second
protein
pth
relat
protein
pthrp
secret
varieti
tissu
act
autocrin
paracrin
signal
use
pthrp
modul
wide
rang
physiolog
development
respons
goltzman
white
mice
target
mutat
pth
pthrp
gene
demonstr
critic
role
protein
regul
switch
prolifer
differenti
chondrocyt
replac
bone
cell
schipani
provost
serum
level
pth
may
quantifi
mice
use
commerci
avail
elisa
kit
also
use
quantifi
protein
rat
hormon
elisa
kit
commerci
avail
quantifi
mani
addit
hormon
serum
mice
includ
insulin
leptin
gh
epinephrin
orexin
orexin
b
adiponectin
adipsin
resistin
hormon
briefli
discuss
glucos
carbohydr
metabol
section
liver
mani
complex
function
includ
protein
metabol
carbohydr
metabol
lipid
metabol
liver
involv
synthesi
mani
plasma
protein
includ
albumin
convers
ammonia
urea
product
glucos
glucogen
amino
acid
liver
implic
regul
blood
glucos
level
via
glycogenolysi
gluconeogenesi
discuss
glucos
carbohydr
metabol
section
remov
glucos
blood
via
membran
transport
storag
form
glycogen
liver
also
involv
cholesterol
triglycerid
synthesi
format
lipoprotein
discuss
lipid
metabol
section
synthesi
carbohydr
fat
also
specif
function
liver
facilit
includ
synthesi
heme
synthesi
mani
coenzym
detoxificationbiotransform
exogen
endogen
substanc
via
cytochrom
microsom
enzym
synthesi
bile
role
liver
function
variou
anim
review
tennant
woodman
elev
plasma
serum
enzym
usual
confin
cytosol
mitochondria
hepatocyt
help
elucid
liver
injuri
mani
factor
influenc
durat
elev
serum
enzym
level
includ
molecular
size
intracellular
locat
rate
plasma
clearanc
rate
enzym
inactiv
hepat
product
hepat
necrosi
associ
elev
alt
ast
sd
otc
mice
extrahepat
cholestasi
associ
elev
ap
tennant
pleas
refer
enzym
section
descript
enzym
bilirubin
pigment
produc
degrad
hemoglobin
cell
mononuclear
phagocyt
system
two
main
type
bilirubin
unconjug
bilirubin
nonwat
solubl
molecul
transport
blood
bound
albumin
hepatocyt
uptak
unconjug
bilirubin
undergo
glucuronid
produc
watersolubl
form
conjug
bilirubin
conjug
bilirubin
excret
via
hepatobiliari
system
excret
bile
quantif
serum
bilirubin
level
base
van
den
bergh
diazo
reaction
diazo
react
directli
conjug
bilirubin
unconjug
bilirubin
addit
alcohol
reaction
therefor
measur
serum
bilirubin
involv
follow
step
first
level
conjug
bilirubin
measur
second
alcohol
ad
reactant
allow
quantif
total
bilirubin
level
final
level
unconjug
bilirubin
determin
subtract
conjug
measur
total
measur
excretori
capac
liver
may
assess
measur
serum
bilirubin
elev
level
unconjug
bilirubin
usual
observ
situat
increas
erythrocyt
breakdown
hemolyt
diseas
unconjug
hyperbilirubinemia
also
seen
diseas
hepat
uptak
conjug
secret
bilirubin
diminish
increas
level
conjug
bilirubin
usual
associ
intrahepat
cholestasi
extrahepat
bile
duct
obstruct
conjug
bilirubin
blood
normal
filter
glomerulu
small
amount
conjug
hyperbilirubinemia
may
result
bilirubinuria
tennant
bilirubin
clearanc
blood
role
constitut
androstan
receptor
process
studi
normal
transgen
mice
huang
et
al
studi
document
bilirubinmetabolismdetoxifi
enzym
regulatori
nuclear
receptor
lipid
transport
mice
report
wagner
et
al
bile
acid
cholesterol
breakdown
product
secret
hepatocyt
hepatobiliari
system
ultim
intestin
tract
bile
acid
aid
digest
emulsifi
dietari
lipid
aggreg
solubil
transport
lipid
aqueou
environ
particular
fatsolubl
vitamin
liver
bile
acid
also
play
role
regul
secret
apolipoprotein
b
elzinga
et
al
extens
enterohepat
recircul
result
almost
return
bile
acid
secret
liver
intestin
tract
absorpt
occur
mainli
ileum
influenc
apic
na
bile
acid
transport
epitheli
cell
kida
et
al
absorpt
also
take
place
larg
intestin
absorb
conjug
bile
acid
ileum
pass
unalt
portal
circul
remov
nataurochol
cotransport
polypeptid
locat
basolater
hepatocyt
membran
jung
et
al
two
type
bile
acid
cholic
acid
chenodeoxychol
acid
mice
conjug
taurin
secret
liver
liverspecif
enzym
bile
acid
coa
ligas
bile
acidcoa
amino
acid
nacyltransferas
respons
conjug
inou
et
al
stedman
et
al
describ
normal
serum
bile
acid
level
normal
transgen
mice
elev
serum
bile
acid
level
mice
usual
due
decreas
bile
acid
recycl
liver
mainli
includ
diseas
associ
decreas
hepat
function
mass
cholestasi
tennant
hoda
green
measur
increas
level
serum
bile
acid
bile
duct
ligat
albumin
nonglycosyl
protein
abund
protein
plasma
serv
import
determin
plasma
oncot
pressur
major
transport
protein
endogen
metabolit
xenobiot
made
exclus
liver
serum
albumin
may
measur
radial
immunodiffus
dye
bind
reaction
use
bromcresol
green
bromcresol
purpl
electrophoresi
elisa
serum
albumin
level
decreas
age
mani
inbr
strain
quimbi
hypoalbuminemia
usual
reflect
decreas
hepat
synthesi
due
hepat
diseas
inflamm
malabsorptivemaldigest
diseas
increas
loss
due
hemorrhag
via
intestin
tract
proteinlos
enteropathi
kidney
proteinlos
nephropathi
tennant
protein
associ
coagul
synthes
liver
except
factor
viii
measur
fibrinogen
prothrombin
time
serv
marker
decreas
synthesi
due
hepat
injuri
tennant
prothrombin
time
also
increas
due
consumpt
clot
compon
vitamin
k
defici
fibrinogen
also
acut
phase
reactant
plasma
elev
seen
inflamm
tennant
fibrinogen
may
quantifi
mous
plasma
elisa
ceruloplasmin
coppercontain
acut
phase
reactant
iron
transport
protein
made
exclus
hepatocyt
mice
serum
level
may
decreas
hepat
injuri
increas
respons
inflammatori
stimuli
min
et
al
shim
harri
mani
complement
compon
also
made
mous
liver
especi
factor
b
decreas
circul
level
may
seen
due
hepat
injuri
due
consumpt
activ
pleas
refer
complement
section
detail
complement
function
measur
two
dye
sulfobromophthalein
indocyanin
green
use
assess
hepatocellular
bile
tract
function
follow
intraven
bolu
dye
rapidli
clear
plasma
hepatocyt
excret
bile
dye
use
assess
liver
function
mice
hurwitz
et
al
huang
vore
kidney
play
complex
role
maintain
homeostasi
bodi
involv
function
water
electrolyt
balanc
nutrient
conserv
mainten
blood
ph
remov
end
product
nitrogen
metabol
urea
creatinin
allantoin
addit
kidney
produc
respond
varieti
hormon
howev
assess
renal
function
complic
larg
function
reserv
kidney
instanc
increas
urea
nitrogen
occur
renal
mass
becom
function
compromis
addit
assess
analyt
urin
difficult
due
small
size
mice
discuss
sampl
section
urea
produc
liver
wast
product
protein
catabol
specif
breakdown
product
ammonia
urea
small
molecul
freeli
diffus
across
cell
membran
therefor
urea
concentr
blood
serum
plasma
tradit
urea
concentr
measur
term
urea
nitrogen
amount
nitrogen
contain
within
urea
determin
urea
nitrogen
usual
made
serum
whole
blood
use
henc
term
blood
urea
nitrogen
bun
quantif
urea
nitrogen
base
spectrophotometri
assay
measur
amount
urea
hydrolyz
ureas
frith
et
al
investig
urea
nitrogen
level
balbc
mice
urea
nitrogen
level
decreas
month
age
increas
month
sex
balbc
mice
level
higher
male
femal
wherea
mice
femal
significantli
higher
level
male
elev
urea
nitrogen
azotemia
caus
preren
renal
postren
condit
preren
caus
includ
increas
protein
catabol
inflamm
starvat
highprotein
diet
renal
caus
usual
associ
condit
compromis
function
renal
mass
includ
condit
renal
amyloidosi
glomerular
immun
complex
diseas
polycyst
diseas
postren
includ
caus
result
obstruct
lower
urinari
system
decreas
urea
nitrogen
found
diseas
associ
hepat
insuffici
lowprotein
diet
creatinin
degrad
product
creatin
creatin
phosphat
repres
endproduct
muscl
metabol
quantif
creatinin
base
spectrophotometri
assay
baselin
serum
level
directli
relat
muscular
condit
total
muscular
mass
vari
individu
patholog
elev
serum
creatinin
level
caus
preren
renal
postren
caus
elev
urea
nitrogen
serum
therefor
quantif
serum
creatinin
offer
interpret
advantag
urea
nitrogen
everett
harrison
proteinuria
common
find
normal
mice
includ
rodentspecif
protein
uromucoid
small
quantiti
cand
famili
prealbumin
known
major
urinari
protein
mup
mup
three
electrophoret
variant
design
genet
hormon
control
regulatori
locu
design
codominantli
express
allel
b
locat
chromosom
control
urinari
level
three
variant
mup
synthes
liver
secret
blood
excret
urin
male
higher
level
proteinuria
femal
level
mgml
agerel
increas
seen
mice
sex
increas
urinari
protein
associ
varieti
renal
diseas
mice
concentr
urin
amount
solut
dissolv
urin
measur
urin
specif
graviti
usg
osmol
urin
concentr
healthi
mice
high
watt
determin
usg
healthi
cba
mice
rang
author
also
found
usg
increas
day
age
urin
concentr
abil
transgen
mice
express
human
sickl
cell
hemoglobin
ko
mous
hb
assess
ryan
et
al
found
sickl
cell
caus
vascular
tubular
glomerular
chang
well
correspond
hyposthenuria
water
depriv
osmol
affect
mice
mosm
compar
mosm
control
electrolyt
sodium
potassium
chlorid
phosphoru
sodium
potassium
level
easili
measur
murin
serum
use
flame
photometri
lithium
refer
ionspecif
electrod
serum
sodium
level
slightli
higher
mice
mammalian
speci
report
valu
sd
finch
foster
sd
meql
everett
harrison
loeb
et
al
differ
serum
sodium
seen
age
sex
among
strain
serum
chlorid
measur
use
mercur
thiocyan
chloridimetr
ionspecif
electrod
techniqu
inorgan
phosphoru
mice
measur
use
phosphomolybd
techniqu
serum
inorgan
phosphoru
level
decreas
mice
age
month
chang
document
balbc
strain
well
outbr
mice
loeb
et
al
total
serum
calcium
reflect
ioniz
activ
calcium
proteinbound
calcium
mainli
bound
albumin
ioniz
calcium
biolog
activ
bone
format
neuromuscular
activ
cellular
biochem
process
blood
coagul
decreas
serum
albumin
level
also
expect
decreas
total
calcium
level
decreas
amount
proteinbound
calcium
howev
hypoalbuminemia
result
clinic
sign
hypocalcemia
mice
total
serum
calcium
measur
use
sodium
alizarin
sulfon
techniqu
atom
absorpt
spectrometri
two
report
use
differ
techniqu
list
similar
refer
rang
sd
mgdl
wherea
third
report
list
refer
rang
sd
mgdl
male
sd
mgdl
femal
albino
mice
latter
valu
report
male
mice
significantli
lower
six
inbr
strain
mice
two
differ
agegroup
use
techniqu
quimbi
likewis
differ
associ
sex
report
everett
harrison
also
examin
random
bred
albino
mice
howev
bonella
et
al
demonstr
significantli
higher
level
femal
swiss
albino
mice
serum
calcium
level
appear
declin
month
age
balbc
strain
well
outbr
mice
frith
et
al
found
femal
mice
lower
calcium
level
male
bonella
et
al
demonstr
significantli
elev
calcium
level
blood
collect
orbit
punctur
versu
cardiac
punctur
hypercalcemia
mice
result
respons
increas
level
pth
hyperparathyroid
pthrp
certain
neoplasm
like
multipl
myeloma
mice
respons
parathyroid
chief
cell
hypercalcemia
appear
differ
speci
grone
et
al
studi
respons
nude
mice
pthrp
secret
tumor
cell
infus
pthrp
found
promin
membran
whorl
increas
cytoplasm
area
chief
cell
mice
hypercalcemia
mgdl
mark
cell
distinctli
differ
parathyroid
chief
cell
speci
hypocalcemia
due
hypoalbuminemia
previous
discuss
renal
diseas
pancreat
hypomagnesemia
alcock
shil
found
mice
fed
magnesiumdefici
diet
develop
hypocalcemia
mice
receiv
intramuscular
inject
heparin
total
serum
protein
evalu
mice
use
either
lowri
biuret
method
although
lowri
method
prefer
analysi
small
volum
sampl
hypoproteinemia
seen
hepat
injuri
also
see
liver
function
test
section
proteinlos
enteropathi
nephropathi
hyperproteinemia
seen
dehydr
agerel
chang
describ
number
strain
increas
total
serum
protein
older
balbc
mice
lower
level
mice
loeb
et
al
major
class
serum
protein
xl
yglobulin
mice
distinguish
electrophoresi
chang
serum
level
associ
wide
varieti
diseas
mice
instanc
hypergammaglobulinemia
found
scid
mice
inject
human
cag
multipl
myeloma
cell
acut
phase
reactant
ceruloplasmin
fibrinogen
discuss
serum
protein
section
crp
sap
complement
section
saa
acut
phase
reactant
synthes
liver
may
induc
inflammatori
cytokin
see
cytokin
chemokin
section
normal
saa
quickli
cleav
small
molecular
weight
product
chronic
infect
failur
degrad
pathway
tissu
deposit
amyloid
may
occur
differ
serum
concentr
describ
variou
mous
strain
diseas
commerci
ria
elisa
kit
avail
quantit
mice
quimbi
afp
encod
afp
gene
nearli
ident
organ
mous
albumin
gene
albl
like
afp
aros
due
gene
duplic
afp
present
fetal
serum
synthesi
declin
shortli
birth
serum
level
regul
two
loci
link
afp
action
gene
may
modifi
tgf
wilkinson
et
al
level
mous
serum
quantifi
immunoelectrophoresi
zizkovski
polyclon
antibodi
recombin
dnaderiv
mous
afp
avail
assay
develop
boismenu
et
al
elev
mice
certain
neoplasm
hepat
regener
jin
et
al
quimbi
